Background	Background	NN	0
The	The	DT	0
actin	actin	JJ	B-NP
cytoskeleton	cytoskeleton	NN	I-NP
is	is	VBZ	0
a	a	DT	0
dynamic	dynamic	JJ	B-NP
system	system	NN	I-NP
composed	composed	VBN	0
of	of	IN	0
actin	actin	JJ	B-NP
filament	filament	NN	I-NP
,	,	,	0
proteins	proteins	NNS	0
that	that	IN	0
regulate	regulate	JJ	0
filament	filament	JJ	0
dynamics	dynamics	NNS	0
,	,	,	0
and	and	CC	0
proteins	proteins	NNS	0
that	that	IN	0
remodel	remodel	NN	0
and	and	CC	0
make	make	VB	0
use	use	NN	0
of	of	IN	0
the	the	DT	0
cytoskeletal	cytoskeletal	JJ	B-NP
network	network	NN	I-NP
.	.	.	0
An	An	DT	0
important	important	JJ	0
actin	actin	JJ	B-NP
cytoskeletal	cytoskeletal	JJ	I-NP
research	research	NN	I-NP
aspect	aspect	NN	I-NP
has	has	VBZ	0
been	been	VBN	0
the	the	DT	0
use	use	NN	0
of	of	IN	0
small	small	JJ	0
molecules	molecules	NNS	0
that	that	WDT	0
affect	affect	VBP	0
actin	actin	JJ	B-NP
dynamic	dynamic	JJ	I-NP
and	and	CC	0
proteins	proteins	NNS	0
that	that	IN	0
act	act	NN	0
on	on	IN	0
the	the	DT	0
cytoskeleton	cytoskeleton	NN	B-NP
[	[	-LRB-	0
1	1	LS	0
]	]	-RRB-	0
.	.	.	0
2,3-butanedione	2,3-butanedione	FW	0
monoxime	monoxime	FW	0
(	(	-LRB-	0
BDM	BDM	NNP	B-NP
)	)	-RRB-	0
is	is	VBZ	0
a	a	DT	0
small	small	JJ	0
molecule	molecule	NN	B-NP
that	that	IN	0
inhibits	inhibits	VBG	0
the	the	DT	0
muscle	muscle	NN	B-NP
myosinii	myosinii	NN	I-NP
atpase	atpase	NN	I-NP
activity	activity	NN	I-NP
and	and	CC	0
reduces	reduces	VBZ	0
the	the	DT	0
force	force	NN	0
generated	generated	VBD	0
by	by	IN	0
this	this	DT	0
motor	motor	NN	B-NP
protein	protein	NN	I-NP
[	[	-LRB-	0
2	2	CD	0
3	3	CD	0
]	]	-RRB-	0
.	.	.	0
butanedione	butanedione	NN	B-NP
monoxime	monoxime	NN	I-NP
was	was	VBD	0
introduced	introduced	VBN	0
to	to	TO	0
the	the	DT	0
cell	cell	NN	0
biology	biology	NN	0
community	community	NN	0
as	as	IN	0
a	a	DT	0
millimolar	millimolar	JJ	B-NP
inhibitor	inhibitor	NN	I-NP
of	of	IN	0
multiple	multiple	JJ	0
non-muscle	non-muscle	JJ	B-NP
myosin	myosin	NN	I-NP
with	with	IN	0
greatest	greatest	JJS	0
potency	potency	NN	0
in	in	IN	0
inhibiting	inhibiting	JJ	0
non-muscle	non-muscle	JJ	B-NP
myosinII	myosinII	NN	I-NP
[	[	-LRB-	0
4	4	LS	0
]	]	-RRB-	0
.	.	.	0
It	It	PRP	0
was	was	VBD	0
subsequently	subsequently	RB	0
used	used	VBN	0
,	,	,	0
in	in	IN	0
concert	concert	NN	0
with	with	IN	0
other	other	JJ	0
approaches	approaches	NNS	0
,	,	,	0
to	to	TO	0
study	study	VB	0
nm-myosinII	nm-myosinII	JJ	B-NP
function	function	NN	I-NP
in	in	IN	0
a	a	DT	0
variety	variety	NN	0
of	of	IN	0
biological	biological	JJ	B-NP
process	process	NN	I-NP
[	[	-LRB-	0
5	5	CD	0
6	6	CD	0
7	7	CD	0
8	8	CD	0
]	]	-RRB-	0
.	.	.	0
butanedione	butanedione	NN	B-NP
monoxime	monoxime	NN	I-NP
was	was	VBD	0
recently	recently	RB	0
shown	shown	VBN	0
not	not	RB	0
to	to	TO	0
inhibit	inhibit	VB	0
any	any	DT	0
non-muscle	non-muscle	JJ	B-NP
myosin	myosin	NN	I-NP
so	so	RB	0
far	far	RB	0
tested	tested	VBN	0
,	,	,	0
leaving	leaving	VBG	0
the	the	DT	0
question	question	NN	0
of	of	IN	0
how	how	WRB	0
it	it	PRP	0
affects	affects	VBZ	0
cells	cells	JJ	0
unanswered	unanswered	NNS	0
[	[	-LRB-	0
9	9	CD	0
10	10	CD	0
]	]	-RRB-	0
.	.	.	0
One	One	CD	0
process	process	NN	B-NP
inhibited	inhibited	NN	I-NP
by	by	IN	0
butanedione	butanedione	NN	B-NP
monoxime	monoxime	NN	I-NP
is	is	VBZ	0
the	the	DT	0
actin	actin	NN	B-NP
centripetal	centripetal	JJ	I-NP
flow	flow	NN	I-NP
from	from	IN	0
the	the	DT	0
leading	leading	JJ	0
edge	edge	NN	0
into	into	IN	0
the	the	DT	0
cell	cell	NN	0
body	body	NN	0
,	,	,	0
known	known	VBN	0
as	as	IN	0
retrograde	retrograde	JJ	0
flow	flow	NN	0
[	[	-LRB-	0
11	11	CD	0
12	12	CD	0
]	]	-RRB-	0
.	.	.	0
Retrograde	Retrograde	JJ	B-NP
flow	flow	NN	I-NP
is	is	VBZ	0
thought	thought	VBN	0
to	to	TO	0
be	be	VB	0
driven	driven	VBN	0
by	by	IN	0
a	a	DT	0
"push-pull	"push-pull	NN	0
"	"	''	0
mechanism	mechanism	NN	0
of	of	IN	0
actin	actin	NN	B-NP
polymerization	polymerization	NN	I-NP
at	at	IN	0
the	the	DT	0
leading	leading	JJ	0
edge	edge	NN	0
of	of	IN	0
the	the	DT	0
cell	cell	NN	0
and	and	CC	0
contractile	contractile	JJ	0
activity	activity	NN	0
of	of	IN	0
myosin	myosin	JJ	B-NP
motor	motor	NN	I-NP
protein	protein	NN	I-NP
[	[	-LRB-	0
13	13	CD	0
14	14	CD	0
]	]	-RRB-	0
.	.	.	0
Formation	Formation	NN	0
of	of	IN	0
new	new	JJ	0
actin	actin	JJ	B-NP
filament	filament	NN	I-NP
is	is	VBZ	0
predominantly	predominantly	RB	0
mediated	mediated	VBN	0
by	by	IN	0
the	the	DT	0
arp2	arp2	NN	B-NP
nucleation	nucleation	JJ	I-NP
activity	activity	NN	I-NP
/	/	CD	0
3	3	CD	0
complex	complex	NN	0
[	[	-LRB-	0
15	15	CD	0
]	]	-RRB-	0
.	.	.	0
Members	Members	NNS	0
of	of	IN	0
the	the	DT	0
WASP	WASP	NNP	B-NP
/	/	NNP	I-NP
WAVE	WAVE	NNP	I-NP
family	family	NN	I-NP
of	of	IN	0
proteins	proteins	NNS	0
,	,	,	0
among	among	IN	0
others	others	NNS	0
,	,	,	0
stimulate	stimulate	NN	0
and	and	CC	0
regulate	regulate	VB	0
the	the	DT	0
Arp2	Arp2	CD	B-NP
/	/	CD	0
3	3	CD	0
complex	complex	NN	0
for	for	IN	0
spatial	spatial	NN	0
and	and	CC	0
filament	filament	JJ	B-NP
nucleation	nucleation	NNS	I-NP
temporal	temporal	JJ	I-NP
control	control	NN	I-NP
[	[	-LRB-	0
15	15	CD	0
]	]	-RRB-	0
.	.	.	0
Localization	Localization	NNP	B-NP
of	of	IN	0
these	these	DT	0
proteins	proteins	NNS	0
to	to	TO	0
the	the	DT	0
leading	leading	JJ	0
edge	edge	NN	0
,	,	,	0
though	though	RB	0
not	not	RB	0
completely	completely	RB	0
understood	understood	VBN	0
,	,	,	0
is	is	VBZ	0
probably	probably	RB	0
mediated	mediated	VBN	0
through	through	IN	0
their	their	PRP$	0
interaction	interaction	NN	B-NP
with	with	IN	0
the	the	DT	0
actin	actin	NN	B-NP
cytoskeleton	cytoskeleton	VBD	0
itself	itself	PRP	0
and	and	CC	0
membrane-associated	membrane-associated	JJ	0
binding	binding	JJ	0
partners	partners	NNS	0
[	[	-LRB-	0
15	15	CD	0
16	16	CD	0
]	]	-RRB-	0
.	.	.	0
Inhibition	Inhibition	NNP	0
of	of	IN	0
retrograde	retrograde	JJ	0
flow	flow	NN	0
by	by	IN	0
butanedione	butanedione	NN	B-NP
monoxime	monoxime	NN	I-NP
has	has	VBZ	0
been	been	VBN	0
used	used	VBN	0
as	as	IN	0
evidence	evidence	NN	0
for	for	IN	0
the	the	DT	0
role	role	NN	0
of	of	IN	0
nm-myosin	nm-myosin	NN	B-NP
in	in	IN	0
retrograde	retrograde	JJ	0
flow	flow	NN	0
[	[	-LRB-	0
12	12	CD	0
]	]	-RRB-	0
.	.	.	0
Though	Though	RB	0
not	not	RB	0
explicitly	explicitly	RB	0
stated	stated	VBN	0
,	,	,	0
the	the	DT	0
localization	localization	NN	B-NP
and	and	CC	0
importance	importance	NN	0
of	of	IN	0
nm-myosinII	nm-myosinII	JJ	B-NP
in	in	IN	0
multiple	multiple	JJ	0
cell	cell	NN	0
types	types	NNS	0
,	,	,	0
and	and	CC	0
the	the	DT	0
fact	fact	NN	0
that	that	IN	0
butanedione	butanedione	NN	B-NP
monoxime	monoxime	NN	I-NP
was	was	VBD	0
thought	thought	VBN	0
to	to	TO	0
have	have	VB	0
greatest	greatest	JJS	0
potency	potency	NN	0
in	in	IN	0
inhibiting	inhibiting	JJ	0
nm-myosinII	nm-myosinII	NN	B-NP
has	has	VBZ	0
led	led	VBN	0
most	most	RBS	0
to	to	TO	0
look	look	VB	0
at	at	IN	0
BDM	BDM	NNP	0
's	's	POS	0
effect	effect	NN	0
on	on	IN	0
retrograde	retrograde	JJ	0
flow	flow	NN	0
as	as	IN	0
a	a	DT	0
result	result	NN	0
of	of	IN	0
inhibiting	inhibiting	VBG	0
this	this	DT	0
protein.	protein.	NNP	B-NP
[	[	-LRB-	0
11	11	CD	0
17	17	CD	0
18	18	CD	0
]	]	-RRB-	0
.	.	.	0
A	A	DT	0
role	role	NN	0
for	for	IN	0
nm-myosinII	nm-myosinII	NNP	B-NP
may	may	MD	0
exist	exist	VB	0
,	,	,	0
given	given	VBN	0
its	its	PRP$	0
localization	localization	NN	B-NP
and	and	CC	0
that	that	DT	0
other	other	JJ	0
perturbation	perturbation	NN	B-NP
that	that	WDT	0
affect	affect	VBP	0
myosin	myosin	JJ	B-NP
function	function	NN	I-NP
-	-	:	0
myosin	myosin	CD	B-NP
S1	S1	CD	I-NP
microinjection	microinjection	NN	I-NP
,	,	,	0
ML-7	ML-7	CD	B-NP
treatment	treatment	NN	I-NP
,	,	,	0
and	and	CC	0
expression	expression	NN	0
of	of	IN	0
dominant	dominant	JJ	0
negative	negative	JJ	B-NP
nm-myosinII	nm-myosinII	JJ	I-NP
constructs	constructs	NN	0
and	and	CC	0
have	have	VBP	0
similar	similar	JJ	0
effects	effects	NNS	0
to	to	TO	0
BDM	BDM	NNP	B-NP
treatment	treatment	NN	I-NP
[	[	-LRB-	0
5	5	CD	0
7	7	CD	0
12	12	CD	0
]	]	-RRB-	0
.	.	.	0
However	However	RB	0
,	,	,	0
a	a	DT	0
study	study	NN	0
in	in	IN	0
chick	chick	JJ	0
dorsal	dorsal	NN	B-NP
root	root	VBP	0
ganglia	ganglia	JJ	B-NP
neuron	neuron	NN	I-NP
where	where	WRB	0
nm-myosinII	nm-myosinII	NNP	B-NP
was	was	VBD	0
inactivated	inactivated	VBN	0
using	using	VBG	0
chromophore	chromophore	JJ	B-NP
assisted	assisted	JJ	I-NP
laser	laser	NN	I-NP
inactivation	inactivation	NN	I-NP
saw	saw	VBD	0
no	no	DT	0
effect	effect	NN	0
on	on	IN	0
retrograde	retrograde	JJ	0
flow	flow	NN	B-NP
rate	rate	NN	I-NP
[	[	-LRB-	0
19	19	CD	0
]	]	-RRB-	0
.	.	.	0
We	We	PRP	0
know	know	VBP	0
now	now	RB	0
that	that	IN	0
butanedione	butanedione	NN	B-NP
monoxime	monoxime	NN	I-NP
does	does	VBZ	0
not	not	RB	0
in	in	IN	0
fact	fact	NN	0
inhibit	inhibit	VBP	0
nm-myosinII	nm-myosinII	JJ	B-NP
.	.	.	0
So	So	RB	0
,	,	,	0
is	is	VBZ	0
this	this	DT	0
effect	effect	NN	0
that	that	IN	0
we	we	PRP	0
see	see	VBP	0
with	with	IN	0
BDM	BDM	NNP	B-NP
mediated	mediated	NN	I-NP
by	by	IN	0
other	other	JJ	0
proteins	proteins	NNS	0
involved	involved	VBN	0
in	in	IN	0
retrograde	retrograde	JJ	0
flow	flow	NN	0
?	?	.	0
And	And	CC	0
what	what	WP	0
can	can	MD	0
this	this	RB	0
tell	tell	VB	0
us	us	PRP	0
about	about	IN	0
the	the	DT	0
mechanism	mechanism	NN	0
of	of	IN	0
retrograde	retrograde	JJ	0
flow	flow	NN	0
?	?	.	0
How	How	WRB	0
similar	similar	JJ	0
is	is	VBZ	0
this	this	DT	0
process	process	NN	0
to	to	TO	0
other	other	JJ	0
actin	actin	JJ	B-NP
mediated	mediated	JJ	I-NP
process	process	NN	I-NP
that	that	WDT	0
use	use	VBP	0
these	these	DT	0
same	same	JJ	0
proteins	proteins	NNS	0
,	,	,	0
such	such	JJ	0
as	as	IN	0
Listeria	Listeria	NNP	B-NP
motility	motility	NN	I-NP
?	?	.	0
butanedione	butanedione	NN	B-NP
monoxime	monoxime	NN	I-NP
has	has	VBZ	0
a	a	DT	0
clear	clear	JJ	0
effect	effect	NN	0
on	on	IN	0
a	a	DT	0
number	number	NN	0
of	of	IN	0
cell	cell	NN	0
biological	biological	JJ	B-NP
process	process	NN	I-NP
.	.	.	0
Understanding	Understanding	NN	0
how	how	WRB	0
these	these	DT	0
effects	effects	NNS	0
are	are	VBP	0
mediated	mediated	NNS	0
can	can	MD	0
help	help	VB	0
us	us	PRP	0
learn	learn	VBP	0
from	from	IN	0
butanedione	butanedione	NN	B-NP
monoxime	monoxime	NN	I-NP
and	and	CC	0
reinterpret	reinterpret	JJ	0
experiments	experiments	NNS	0
that	that	WDT	0
made	made	VBD	0
use	use	NN	0
of	of	IN	0
it	it	PRP	0
,	,	,	0
while	while	IN	0
working	working	VBG	0
to	to	TO	0
find	find	VB	0
new	new	JJ	0
and	and	CC	0
better	better	JJR	0
inhibitors	inhibitors	NN	0
.	.	.	0
Results	Results	FW	0
butanedione	butanedione	NN	B-NP
monoxime	monoxime	NN	I-NP
inhibits	inhibits	FW	0
actin	actin	NN	B-NP
incorporation	incorporation	NN	I-NP
in	in	FW	0
butanedione	butanedione	NN	B-NP
monoxime	monoxime	NN	I-NP
mammalian	mammalian	NN	I-NP
cell	cell	NN	I-NP
has	has	VBZ	0
been	been	VBN	0
reported	reported	VBN	0
to	to	TO	0
not	not	RB	0
inhibit	inhibit	VB	0
atpase	atpase	NN	B-NP
activity	activity	NN	I-NP
nm-myosinii	nm-myosinii	NN	I-NP
[	[	-LRB-	0
9	9	CD	0
]	]	-RRB-	0
.	.	.	0
We	We	PRP	0
show	show	VBP	0
data	data	NNS	0
[	[	-LRB-	0
Figure	Figure	NNP	0
1A	1A	NNP	0
]	]	-RRB-	0
that	that	WDT	0
supports	supports	VBZ	0
this	this	DT	0
report	report	NN	0
.	.	.	0
The	The	DT	0
platelet	platelet	JJ	B-NP
nm-myosinii	nm-myosinii	NN	I-NP
s1	s1	NN	I-NP
fragment	fragment	NN	I-NP
atpase	atpase	NN	I-NP
activity	activity	NN	I-NP
,	,	,	0
is	is	VBZ	0
not	not	RB	0
inhibited	inhibited	VBN	0
by	by	IN	0
butanedione	butanedione	NN	B-NP
monoxime	monoxime	NN	I-NP
while	while	IN	0
the	the	DT	0
inhibitor	inhibitor	NN	0
,	,	,	0
blebbistatin	blebbistatin	NN	B-NP
,	,	,	0
decreases	decreases	VBZ	0
ATPase	ATPase	JJ	B-NP
activity	activity	NN	I-NP
by	by	IN	0
more	more	JJR	0
than	than	IN	0
90	90	CD	0
%	%	NN	0
.	.	.	0
The	The	DT	0
stimulation	stimulation	NN	0
of	of	IN	0
ATPase	ATPase	JJ	B-NP
activity	activity	NN	I-NP
by	by	IN	0
butanedione	butanedione	NN	B-NP
monoxime	monoxime	NN	I-NP
[	[	-LRB-	0
Figure	Figure	NNP	0
1A	1A	NNP	0
]	]	-RRB-	0
is	is	VBZ	0
similar	similar	JJ	0
to	to	TO	0
a	a	DT	0
~2	~2	JJ	0
fold	fold	JJ	0
increase	increase	NN	0
seen	seen	VBN	0
previously	previously	RB	0
(	(	-LRB-	0
A	A	NNP	0
.	.	.	0
Straight	Straight	RB	0
personal	personal	JJ	B-NP
communication	communication	NN	I-NP
)	)	-RRB-	0
.	.	.	0
Though	Though	IN	0
butanedione	butanedione	NN	B-NP
monoxime	monoxime	NN	I-NP
does	does	VBZ	0
not	not	RB	0
inhibit	inhibit	VB	0
nm-myosinII	nm-myosinII	JJ	B-NP
,	,	,	0
in	in	IN	0
permeabilized	permeabilized	JJ	B-NP
yeast	yeast	NN	I-NP
(	(	-LRB-	0
S.	S.	NNP	B-NP
cerviseae	cerviseae	CD	I-NP
)	)	-RRB-	0
butanedione	butanedione	NN	B-NP
monoxime	monoxime	NN	I-NP
has	has	VBZ	0
been	been	VBN	0
shown	shown	VBN	0
to	to	TO	0
decrease	decrease	VB	0
exogenous	exogenous	JJ	B-NP
actin	actin	NN	I-NP
incorporation	incorporation	VBN	I-NP
into	into	IN	0
the	the	DT	0
cytoskeleton	cytoskeleton	NN	B-NP
[	[	-LRB-	0
20	20	CD	0
]	]	-RRB-	0
.	.	.	0
This	This	DT	0
process	process	NN	0
of	of	IN	0
actin	actin	JJ	B-NP
incorporation	incorporation	NN	I-NP
requires	requires	VBZ	0
proteins	proteins	NNS	0
involved	involved	VBN	0
in	in	IN	0
actin	actin	JJ	B-NP
filament	filament	JJ	I-NP
formation	formation	NN	I-NP
and	and	CC	0
proteins	proteins	NNS	0
that	that	WDT	0
may	may	MD	0
localize	localize	VB	0
a	a	DT	0
nucleation	nucleation	JJ	B-NP
complex	complex	NN	I-NP
[	[	-LRB-	0
20	20	CD	0
21	21	CD	0
]	]	-RRB-	0
.	.	.	0
To	To	TO	0
determine	determine	VB	0
if	if	IN	0
butanedione	butanedione	NN	B-NP
monoxime	monoxime	NN	I-NP
has	has	VBZ	0
a	a	DT	0
similar	similar	JJ	0
effect	effect	NN	0
on	on	IN	0
actin	actin	JJ	B-NP
incorporation	incorporation	NN	I-NP
in	in	IN	0
mammalian	mammalian	JJ	B-NP
cell	cell	NN	I-NP
,	,	,	0
and	and	CC	0
if	if	IN	0
so	so	RB	0
an	an	DT	0
effect	effect	NN	0
on	on	IN	0
actin	actin	JJ	B-NP
nucleation	nucleation	NN	I-NP
,	,	,	0
spreading	spreading	VBG	0
Swiss3T3	Swiss3T3	CD	0
cells	cells	NNS	0
were	were	VBD	0
treated	treated	VBN	0
briefly	briefly	NN	0
with	with	IN	0
a	a	DT	0
media	media	NN	0
control	control	NN	0
or	or	CC	0
15	15	CD	0
mM	mM	JJ	B-NP
BDM	BDM	NNP	I-NP
and	and	CC	0
then	then	RB	0
permeabilized	permeabilized	VBN	0
with	with	IN	0
the	the	DT	0
detergent	detergent	NN	B-NP
saponin	saponin	NN	I-NP
in	in	IN	0
the	the	DT	0
presence	presence	NN	0
of	of	IN	0
fluorescently	fluorescently	JJ	B-NP
labeled	labeled	JJ	I-NP
actin	actin	NN	I-NP
.	.	.	0
The	The	DT	0
cells	cells	NNS	0
were	were	VBD	0
then	then	RB	0
fixed	fixed	VBN	B-NP
and	and	CC	0
exogenous	exogenous	JJ	B-NP
actin	actin	NN	I-NP
incorporation	incorporation	NN	I-NP
was	was	VBD	0
determined	determined	VBN	0
by	by	IN	0
fluorescence	fluorescence	JJ	0
microscopy	microscopy	NNS	0
[	[	-LRB-	0
22	22	CD	0
]	]	-RRB-	0
.	.	.	0
control	control	NN	B-NP
cell	cell	NN	I-NP
show	show	VBP	0
fluorescent	fluorescent	JJ	0
incorporation	incorporation	NN	B-NP
at	at	IN	0
the	the	DT	0
periphery	periphery	NN	0
,	,	,	0
or	or	CC	0
leading	leading	JJ	0
edge	edge	NN	0
,	,	,	0
of	of	IN	0
the	the	DT	0
cell	cell	NN	0
[	[	-LRB-	0
Figure	Figure	NNP	0
1B	1B	NNP	0
]	]	-RRB-	0
.	.	.	0
Treatment	Treatment	NN	0
of	of	IN	0
cells	cells	NNS	0
with	with	IN	0
15	15	CD	0
mM	mM	JJ	B-NP
BDM	BDM	NN	I-NP
for	for	IN	0
one	one	CD	0
minute	minute	NN	0
blocked	blocked	VBD	B-NP
incorporation	incorporation	VBN	I-NP
at	at	IN	0
the	the	DT	0
leading	leading	JJ	0
edge	edge	NN	0
,	,	,	0
as	as	RB	0
seen	seen	VBN	0
by	by	IN	0
the	the	DT	0
lack	lack	NN	0
of	of	IN	0
fluorescence	fluorescence	JJ	B-NP
intensity	intensity	NN	I-NP
,	,	,	0
without	without	IN	0
significant	significant	JJ	0
effects	effects	NNS	0
on	on	IN	0
cell	cell	NN	0
morphology	morphology	NNS	0
[	[	-LRB-	0
Figure	Figure	NNP	0
1B	1B	NNP	0
]	]	-RRB-	0
.	.	.	0
Cells	Cells	NNS	0
that	that	WDT	0
remained	remained	VBD	0
flat	flat	JJ	0
and	and	CC	0
were	were	VBD	0
not	not	RB	0
disrupted	disrupted	VBN	0
by	by	IN	0
the	the	DT	0
permeabilization	permeabilization	JJ	B-NP
process	process	NN	I-NP
were	were	VBD	0
counted	counted	VBN	0
,	,	,	0
and	and	CC	0
more	more	JJR	0
than	than	IN	0
75	75	CD	0
%	%	NN	0
(	(	-LRB-	0
3	3	CD	0
trials	trials	NNS	0
)	)	-RRB-	0
showed	showed	VBD	0
decreased	decreased	VBN	0
fluorescence	fluorescence	JJ	0
similar	similar	JJ	0
to	to	TO	0
that	that	DT	0
seen	seen	VBN	0
in	in	IN	0
Figure	Figure	NNP	B-NP
1B	1B	NNP	I-NP
(	(	-LRB-	I-NP
cell	cell	NN	I-NP
that	that	WDT	I-NP
showed	showed	VBD	I-NP
significant	significant	JJ	I-NP
perturbation	perturbation	NN	I-NP
by	by	IN	I-NP
the	the	DT	I-NP
permeabilization	permeabilization	JJ	I-NP
process	process	NN	I-NP
did	did	VBD	I-NP
not	not	RB	I-NP
show	show	VB	I-NP
greater	greater	JJR	I-NP
actin	actin	JJ	I-NP
incorporation	incorporation	NN	I-NP
)	)	-RRB-	I-NP
.	.	.	0
Incubation	Incubation	NNP	0
in	in	IN	0
butanedione	butanedione	NN	B-NP
monoxime	monoxime	NN	I-NP
for	for	IN	0
longer	longer	JJR	0
than	than	IN	0
1	1	CD	0
minute	minute	NN	0
caused	caused	VBD	0
more	more	RBR	0
pronounced	pronounced	JJ	0
morphological	morphological	JJ	B-NP
change	change	NN	I-NP
upon	upon	IN	0
permeabilization	permeabilization	NN	B-NP
,	,	,	0
and	and	CC	0
one-minute	one-minute	JJ	B-NP
treatment	treatment	NN	I-NP
was	was	VBD	0
used	used	VBN	0
for	for	IN	0
subsequent	subsequent	JJ	0
experiments	experiments	NNS	0
.	.	.	0
As	As	IN	0
a	a	DT	0
control	control	NN	0
,	,	,	0
cytochalasin	cytochalasin	VBG	0
D	D	NNP	0
,	,	,	0
a	a	DT	0
small	small	JJ	0
molecule	molecule	NN	B-NP
that	that	IN	0
inhibits	inhibits	JJ	0
actin	actin	JJ	B-NP
dynamic	dynamic	JJ	I-NP
by	by	IN	0
capping	capping	VBG	0
the	the	DT	0
actin	actin	JJ	B-NP
filament	filament	NN	I-NP
growing	growing	VBG	I-NP
end	end	NN	I-NP
,	,	,	0
was	was	VBD	0
added	added	VBN	0
to	to	TO	0
cells	cells	NNS	0
.	.	.	0
If	If	IN	0
added	added	VBD	0
prior	prior	RB	0
to	to	TO	0
permeabilization	permeabilization	VB	0
but	but	CC	0
not	not	RB	0
during	during	IN	0
,	,	,	0
exogenous	exogenous	JJ	B-NP
actin	actin	NN	I-NP
was	was	VBD	0
still	still	RB	0
able	able	JJ	0
to	to	TO	0
incorporate	incorporate	VB	0
into	into	IN	0
permeabilized	permeabilized	JJ	B-NP
cell	cell	NN	I-NP
and	and	CC	0
fluorescence	fluorescence	JJ	B-NP
incorporation	incorporation	NN	I-NP
was	was	VBD	0
high	high	JJ	0
,	,	,	0
similar	similar	JJ	0
to	to	TO	0
control	control	VB	0
cells	cells	NNS	0
[	[	-LRB-	0
Figure	Figure	NNP	0
1	1	CD	0
]	]	-RRB-	0
.	.	.	0
As	As	IN	0
cytochalasin	cytochalasin	JJ	0
D	D	NNP	0
has	has	VBZ	0
a	a	DT	0
high	high	JJ	0
affinity	affinity	NN	B-NP
(	(	-LRB-	0
50	50	CD	0
nM	nM	NN	B-NP
)	)	-RRB-	0
for	for	IN	0
the	the	DT	0
actin	actin	JJ	B-NP
filament	filament	NN	I-NP
growing	growing	VBG	I-NP
end	end	NN	I-NP
,	,	,	0
this	this	DT	0
treatment	treatment	NN	0
should	should	MD	0
inhibit	inhibit	VB	0
polymerization	polymerization	VBN	0
of	of	IN	0
existing	existing	VBG	0
filaments	filaments	NNS	0
but	but	CC	0
should	should	MD	0
not	not	RB	0
block	block	VB	0
new	new	JJ	0
filament	filament	JJ	B-NP
formation	formation	NN	I-NP
[	[	-LRB-	0
23	23	CD	0
]	]	-RRB-	0
.	.	.	0
Thus	Thus	RB	0
the	the	DT	0
actin	actin	NN	B-NP
incorporated	incorporated	VBN	0
most	most	RBS	0
likely	likely	RB	0
reflects	reflects	VBZ	0
nucleation	nucleation	VBN	0
of	of	IN	0
new	new	JJ	0
filaments	filaments	NN	0
,	,	,	0
as	as	RB	0
previously	previously	RB	0
discussed	discussed	VBN	0
[	[	-LRB-	0
24	24	CD	0
]	]	-RRB-	0
.	.	.	0
As	As	RB	0
expected	expected	VBN	0
,	,	,	0
cells	cells	NNS	0
treated	treated	VBN	0
with	with	IN	0
cytochalasin	cytochalasin	JJ	0
D	D	NNP	0
during	during	IN	0
permeabilization	permeabilization	NN	B-NP
showed	showed	VBD	0
no	no	DT	0
actin	actin	JJ	B-NP
incorporation	incorporation	NN	I-NP
(	(	-LRB-	0
data	data	NNS	0
not	not	RB	0
shown	shown	VBN	0
)	)	-RRB-	0
.	.	.	0
To	To	TO	0
determine	determine	VB	0
if	if	IN	0
butanedione	butanedione	NN	B-NP
monoxime	monoxime	NN	I-NP
was	was	VBD	0
affecting	affecting	VBG	0
actin	actin	JJ	B-NP
dynamic	dynamic	JJ	I-NP
directly	directly	RB	0
,	,	,	0
we	we	PRP	0
assayed	assayed	VBD	0
its	its	PRP$	0
ability	ability	NN	B-NP
to	to	TO	0
inhibit	inhibit	VB	0
in	in	IN	0
vitro	vitro	JJ	B-NP
actin	actin	JJ	I-NP
assembly	assembly	NN	I-NP
.	.	.	0
No	No	DT	0
effect	effect	NN	0
was	was	VBD	0
seen	seen	VBN	0
on	on	IN	0
the	the	DT	0
polymerization	polymerization	NN	B-NP
of	of	IN	0
actin	actin	VBG	0
alone	alone	RB	0
or	or	CC	0
as	as	RB	0
stimulated	stimulated	VBN	0
by	by	IN	0
VCA-activated	VCA-activated	JJ	B-NP
Arp2	Arp2	CD	I-NP
/	/	CD	0
3	3	CD	0
complex	complex	NN	0
,	,	,	0
using	using	VBG	0
a	a	DT	0
polymerization	polymerization	JJ	B-NP
assay	assay	NNS	I-NP
pyrene-actin	pyrene-actin	JJ	I-NP
(	(	-LRB-	0
data	data	NNS	0
not	not	RB	0
shown	shown	VBN	0
)	)	-RRB-	0
.	.	.	0
This	This	DT	0
result	result	NN	0
was	was	VBD	0
supported	supported	VBN	0
by	by	IN	0
the	the	DT	0
observation	observation	NN	0
that	that	IN	0
listeria	listeria	NN	B-NP
monocytogene	monocytogene	NN	I-NP
continue	continue	VBP	0
to	to	TO	0
move	move	VB	0
intracellularly	intracellularly	NNS	0
,	,	,	0
as	as	RB	0
described	described	VBN	0
below	below	RB	0
.	.	.	0
Arp3	Arp3	NNP	B-NP
is	is	VBZ	0
no	no	RB	0
longer	longer	RB	0
localized	localized	VBN	0
at	at	IN	0
the	the	DT	0
leading	leading	JJ	0
edge	edge	NN	0
with	with	IN	0
BDM	BDM	NNP	B-NP
treatment	treatment	NN	I-NP
Since	Since	IN	0
actin	actin	JJ	B-NP
incorporation	incorporation	NN	I-NP
is	is	VBZ	0
not	not	RB	0
due	due	JJ	0
to	to	TO	0
elongation	elongation	VB	0
of	of	IN	0
existing	existing	VBG	0
filaments	filaments	NNS	0
and	and	CC	0
butanedione	butanedione	NN	B-NP
monoxime	monoxime	NN	I-NP
does	does	VBZ	0
not	not	RB	0
affect	affect	VB	0
pure	pure	JJ	0
actin	actin	JJ	B-NP
dynamic	dynamic	JJ	I-NP
in	in	IN	0
vitro	vitro	NN	B-NP
,	,	,	0
we	we	PRP	0
examined	examined	VBD	0
the	the	DT	0
arp3	arp3	NN	B-NP
localization	localization	NN	I-NP
,	,	,	0
a	a	DT	0
actin	actin	JJ	B-NP
nucleation	nucleation	NN	I-NP
arp2	arp2	NN	I-NP
subunit	subunit	NN	I-NP
/	/	CD	0
3	3	CD	0
complex	complex	NN	0
.	.	.	0
In	In	IN	0
spreading	spreading	VBG	0
Swiss3T3	Swiss3T3	CD	0
cells	cells	NNS	0
and	and	CC	0
spread	spread	VBD	0
bs-c-1	bs-c-1	NN	B-NP
cell	cell	NN	I-NP
,	,	,	0
Arp3	Arp3	RB	0
localized	localized	VBN	0
to	to	TO	0
the	the	DT	0
leading	leading	JJ	0
edge	edge	NN	0
of	of	IN	0
the	the	DT	0
cell	cell	NN	0
.	.	.	0
However	However	RB	0
,	,	,	0
after	after	IN	0
treatment	treatment	NN	0
with	with	IN	0
20	20	CD	0
mM	mM	JJ	B-NP
BDM	BDM	NN	I-NP
for	for	IN	0
one	one	CD	0
minute	minute	NN	0
,	,	,	0
localization	localization	NN	B-NP
was	was	VBD	0
lost	lost	VBN	0
in	in	IN	0
over	over	IN	0
90	90	CD	0
%	%	NN	0
of	of	IN	0
the	the	DT	0
cells	cells	NNS	0
[	[	-LRB-	0
Figure	Figure	NNP	0
2A	2A	NNP	0
]	]	-RRB-	0
.	.	.	0
Results	Results	NNS	0
for	for	IN	0
BS-C-1	BS-C-1	NNP	B-NP
and	and	CC	0
Swiss3T3	Swiss3T3	CD	0
cells	cells	NNS	0
lines	lines	NNS	0
were	were	VBD	0
equivalent	equivalent	JJ	0
and	and	CC	0
the	the	DT	0
results	results	NNS	0
from	from	IN	0
bs-c-1	bs-c-1	NN	B-NP
cell	cell	NN	I-NP
are	are	VBP	0
shown	shown	VBN	0
here	here	RB	0
,	,	,	0
as	as	IN	0
they	they	PRP	0
are	are	VBP	0
used	used	VBN	0
in	in	IN	0
subsequent	subsequent	JJ	0
time-lapse	time-lapse	JJ	B-NP
experiment	experiment	NN	I-NP
.	.	.	0
Consistent	Consistent	JJ	0
with	with	IN	0
the	the	DT	0
inhibition	inhibition	NN	0
of	of	IN	0
actin	actin	JJ	B-NP
polymerization	polymerization	NN	I-NP
in	in	IN	0
the	the	DT	0
permeabilized	permeabilized	JJ	B-NP
cell	cell	NN	I-NP
assay	assay	NN	I-NP
,	,	,	0
cells	cells	NNS	0
treated	treated	VBN	0
with	with	IN	0
butanedione	butanedione	NN	B-NP
monoxime	monoxime	NN	I-NP
do	do	VBP	0
not	not	RB	0
show	show	VB	0
a	a	DT	0
brightly	brightly	JJ	0
staining	staining	JJ	0
actin	actin	JJ	B-NP
network	network	NN	I-NP
at	at	IN	0
the	the	DT	0
leading	leading	JJ	0
edge	edge	NN	0
[	[	-LRB-	0
Figure	Figure	NNP	0
2A	2A	NNP	0
,	,	,	0
2B	2B	CD	0
]	]	-RRB-	0
.	.	.	0
butanedione	butanedione	NN	B-NP
monoxime	monoxime	NN	I-NP
titration	titration	NN	I-NP
down	down	RB	0
to	to	TO	0
10	10	CD	0
mM	mM	NN	0
showed	showed	VBD	0
the	the	DT	0
same	same	JJ	0
loss	loss	NN	0
of	of	IN	0
localization	localization	NN	B-NP
;	;	:	0
however	however	RB	0
,	,	,	0
2	2	CD	0
minutes	minutes	NNS	0
of	of	IN	0
treatment	treatment	NN	0
was	was	VBD	0
required	required	VBN	0
to	to	TO	0
see	see	VB	0
equivalent	equivalent	JJ	0
loss	loss	NN	0
(	(	-LRB-	0
data	data	NNS	0
not	not	RB	0
shown	shown	VBN	0
)	)	-RRB-	0
.	.	.	0
To	To	TO	0
control	control	VB	0
for	for	IN	0
possible	possible	JJ	0
bdm	bdm	NN	B-NP
treatment	treatment	NN	I-NP
osmotic	osmotic	JJ	I-NP
effect	effect	NN	I-NP
,	,	,	0
we	we	PRP	0
treated	treated	VBD	0
cells	cells	NNS	0
with	with	IN	0
20	20	CD	0
mM	mM	JJ	B-NP
urea	urea	NN	I-NP
,	,	,	0
and	and	CC	0
as	as	RB	0
with	with	IN	0
a	a	DT	0
media	media	NN	0
control	control	NN	0
,	,	,	0
more	more	JJR	0
than	than	IN	0
90	90	CD	0
%	%	NN	0
of	of	IN	0
the	the	DT	0
cells	cells	NNS	0
arp3	arp3	NN	B-NP
showed	showed	VBD	I-NP
localization	localization	VBN	I-NP
at	at	IN	0
the	the	DT	0
leading	leading	JJ	0
edge	edge	NN	0
.	.	.	0
To	To	TO	0
determine	determine	VB	0
if	if	IN	0
inhibition	inhibition	NN	0
of	of	IN	0
actin	actin	JJ	B-NP
dynamic	dynamic	JJ	I-NP
alone	alone	RB	0
was	was	VBD	0
sufficient	sufficient	JJ	0
for	for	IN	0
the	the	DT	0
loss	loss	NN	0
of	of	IN	0
Arp3	Arp3	CD	B-NP
localization	localization	NN	I-NP
,	,	,	0
we	we	PRP	0
treated	treated	VBD	0
cells	cells	NNS	0
with	with	IN	0
cytochalasin	cytochalasin	JJ	0
D	D	NNP	0
and	and	CC	0
examined	examined	VBD	0
the	the	DT	0
arp3	arp3	NN	B-NP
localization	localization	NN	I-NP
.	.	.	0
Within	Within	IN	0
one	one	CD	0
minute	minute	NN	0
at	at	IN	0
1	1	CD	0
uM	uM	JJ	B-NP
cytochalasin	cytochalasin	JJ	I-NP
D	D	NNP	0
,	,	,	0
cell	cell	NN	0
ruffling	ruffling	NNS	0
ceased	ceased	VBD	0
,	,	,	0
yet	yet	CC	0
Arp3	Arp3	NNP	B-NP
remained	remained	VBD	0
at	at	IN	0
the	the	DT	0
leading	leading	JJ	0
edge	edge	NN	0
[	[	-LRB-	0
Figure	Figure	NNP	0
2A	2A	NNP	0
]	]	-RRB-	0
.	.	.	0
In	In	IN	0
fact	fact	NN	0
,	,	,	0
Arp3	Arp3	CD	B-NP
staining	staining	NN	I-NP
at	at	IN	0
the	the	DT	0
leading	leading	JJ	0
edge	edge	NN	0
was	was	VBD	0
consistently	consistently	RB	0
higher	higher	JJR	0
.	.	.	0
Combining	Combining	VBG	0
cytochalasin	cytochalasin	JJ	0
D	D	NNP	0
and	and	CC	0
butanedione	butanedione	NN	B-NP
monoxime	monoxime	NN	I-NP
,	,	,	0
we	we	PRP	0
saw	saw	VBD	0
localization	localization	JJ	B-NP
equivalent	equivalent	NN	I-NP
to	to	TO	0
or	or	CC	0
greater	greater	JJR	0
than	than	IN	0
no	no	DT	0
drug	drug	NN	B-NP
treatment	treatment	NN	I-NP
[	[	-LRB-	0
Figure	Figure	NNP	0
2A	2A	NNP	0
]	]	-RRB-	0
.	.	.	0
Thus	Thus	RB	0
,	,	,	0
actin	actin	JJ	B-NP
dynamic	dynamic	JJ	I-NP
may	may	MD	0
be	be	VB	0
required	required	VBN	0
for	for	IN	0
the	the	DT	0
loss	loss	NN	0
of	of	IN	0
Arp3	Arp3	CD	B-NP
at	at	IN	0
the	the	DT	0
leading	leading	JJ	0
edge	edge	NN	0
upon	upon	IN	0
BDM	BDM	NNP	B-NP
treatment	treatment	NN	I-NP
.	.	.	0
As	As	RB	0
mentioned	mentioned	VBN	0
,	,	,	0
Listeria	Listeria	NNP	0
infected	infected	JJ	0
cells	cells	NNS	0
were	were	VBD	0
used	used	VBN	0
to	to	TO	0
confirm	confirm	VB	0
that	that	IN	0
BDM	BDM	NNP	0
does	does	VBZ	0
not	not	RB	0
directly	directly	RB	0
affect	affect	VB	0
actin	actin	JJ	0
dynamics	dynamics	NNS	0
.	.	.	0
Listeria	Listeria	RB	0
exploit	exploit	VB	0
cellular	cellular	JJ	0
-	-	:	0
actin	actin	JJ	B-NP
polymerization	polymerization	NN	I-NP
and	and	CC	0
organization	organization	NN	B-NP
-	-	:	0
proteins	proteins	NNS	0
to	to	TO	0
move	move	VB	0
intracellularly	intracellularly	NNS	0
.	.	.	0
We	We	PRP	0
found	found	VBD	0
that	that	IN	0
20	20	CD	0
mM	mM	JJ	B-NP
BDM	BDM	NNP	I-NP
does	does	VBZ	0
not	not	RB	0
affect	affect	VB	0
movement	movement	NN	0
of	of	IN	0
bacteria	bacteria	NNS	0
inside	inside	IN	0
treated	treated	JJ	0
cells	cells	NNS	0
[	[	-LRB-	0
Figure	Figure	NNP	0
3A	3A	NNP	0
]	]	-RRB-	0
consistent	consistent	JJ	0
with	with	IN	0
a	a	DT	0
previous	previous	JJ	0
report	report	NN	0
[	[	-LRB-	0
4	4	LS	0
]	]	-RRB-	0
.	.	.	0
Interestingly	Interestingly	RB	0
,	,	,	0
arp3	arp3	NN	B-NP
localization	localization	VBG	I-NP
in	in	IN	0
listeria	listeria	NN	B-NP
comet	comet	JJ	I-NP
tail	tail	NN	I-NP
is	is	VBZ	0
unaffected	unaffected	VBN	0
with	with	IN	0
BDM	BDM	NNP	B-NP
treatment	treatment	NN	I-NP
[	[	-LRB-	0
Figure	Figure	NNP	0
3B	3B	NNP	0
]	]	-RRB-	0
though	though	IN	0
Arp3	Arp3	CD	B-NP
localization	localization	NN	I-NP
at	at	IN	0
the	the	DT	0
leading	leading	JJ	0
edge	edge	NN	0
of	of	IN	0
these	these	DT	0
cells	cells	NNS	0
is	is	VBZ	0
disrupted	disrupted	VBN	0
.	.	.	0
VASP	VASP	NNP	B-NP
and	and	CC	0
WAVE	WAVE	NNP	0
are	are	VBP	0
no	no	RB	0
longer	longer	RB	0
localized	localized	VBN	0
to	to	TO	0
the	the	DT	0
leading	leading	JJ	0
edge	edge	NN	0
with	with	IN	0
BDM	BDM	NNP	B-NP
treatment	treatment	NN	I-NP
To	To	TO	0
ask	ask	VB	0
whether	whether	IN	0
the	the	DT	0
loss	loss	NN	0
of	of	IN	0
leading	leading	VBG	B-NP
edge	edge	NN	I-NP
localization	localization	NN	I-NP
was	was	VBD	0
specific	specific	JJ	0
to	to	TO	0
the	the	DT	0
Arp	Arp	JJ	B-NP
complex	complex	NN	I-NP
,	,	,	0
we	we	PRP	0
examined	examined	VBD	0
the	the	DT	0
vasp	vasp	NN	B-NP
localization	localization	NN	I-NP
and	and	CC	0
WAVE1	WAVE1	CD	B-NP
with	with	IN	0
BDM	BDM	NNP	B-NP
treatment	treatment	NN	I-NP
.	.	.	0
Both	Both	DT	0
VASP	VASP	NNP	B-NP
and	and	CC	0
WAVE	WAVE	NNP	B-NP
function	function	NN	I-NP
in	in	IN	0
controlling	controlling	VBG	0
actin	actin	JJ	B-NP
dynamic	dynamic	JJ	I-NP
at	at	IN	0
the	the	DT	0
leading	leading	JJ	0
edge	edge	NN	0
-	-	:	0
VASP	VASP	NNP	B-NP
is	is	VBZ	0
thought	thought	VBN	0
to	to	TO	0
promote	promote	VB	0
filament	filament	JJ	B-NP
elongation	elongation	NN	I-NP
,	,	,	0
and	and	CC	0
WAVE	WAVE	NNP	0
,	,	,	0
actin	actin	NN	B-NP
nucleation	nucleation	NN	I-NP
[	[	-LRB-	0
25	25	CD	0
26	26	CD	0
]	]	-RRB-	0
.	.	.	0
Both	Both	DT	0
VASP	VASP	NNP	B-NP
and	and	CC	0
WAVE1	WAVE1	NNP	B-NP
were	were	VBD	0
de-localized	de-localized	JJ	B-NP
from	from	IN	0
the	the	DT	0
leading	leading	JJ	0
edge	edge	NN	0
after	after	IN	0
1	1	CD	0
bdm	bdm	NN	B-NP
treatment	treatment	NN	I-NP
min	min	NN	I-NP
[	[	-LRB-	0
Figure	Figure	NNP	0
4	4	CD	0
]	]	-RRB-	0
.	.	.	0
Similar	Similar	JJ	0
to	to	TO	0
Arp3	Arp3	CD	B-NP
,	,	,	0
the	the	DT	0
localization	localization	NN	B-NP
of	of	IN	0
these	these	DT	0
proteins	proteins	NNS	0
was	was	VBD	0
not	not	RB	0
disrupted	disrupted	VBN	0
by	by	IN	0
cytochalasin	cytochalasin	JJ	0
D	D	NNP	0
treatment	treatment	NN	0
,	,	,	0
or	or	CC	0
by	by	IN	0
the	the	DT	0
combination	combination	NN	0
of	of	IN	0
cytochalasin	cytochalasin	JJ	0
D	D	NNP	0
and	and	CC	0
butanedione	butanedione	NN	B-NP
monoxime	monoxime	NN	I-NP
[	[	-LRB-	0
Figure	Figure	NNP	0
4	4	CD	0
]	]	-RRB-	0
.	.	.	0
Dynamics	Dynamics	NNP	0
of	of	IN	0
the	the	DT	0
loss	loss	NN	0
of	of	IN	0
Arp-3	Arp-3	CD	B-NP
localization	localization	CD	I-NP
Two	Two	CD	0
possible	possible	JJ	0
mechanisms	mechanisms	NNS	0
for	for	IN	0
Arp2	Arp2	CD	B-NP
/	/	CD	0
3	3	CD	0
complex	complex	JJ	0
de-localization	de-localization	NN	B-NP
were	were	VBD	0
considered	considered	VBN	0
:	:	:	0
Arp2	Arp2	CD	B-NP
/	/	CD	0
3	3	CD	0
could	could	MD	0
move	move	VB	0
back	back	RP	0
from	from	IN	0
the	the	DT	0
leading	leading	JJ	0
edge	edge	NN	0
with	with	IN	0
retrograde	retrograde	JJ	0
flow	flow	NN	0
of	of	IN	0
actin	actin	NN	B-NP
and	and	CC	0
then	then	RB	0
be	be	VB	0
lost	lost	VBN	0
from	from	IN	0
the	the	DT	0
filaments	filaments	NN	0
,	,	,	0
or	or	CC	0
it	it	PRP	0
could	could	MD	0
simply	simply	RB	0
diffuse	diffuse	VBN	0
from	from	IN	0
the	the	DT	0
leading	leading	JJ	0
edge	edge	NN	0
.	.	.	0
To	To	TO	0
determine	determine	VB	0
the	the	DT	0
dynamics	dynamics	NNS	0
of	of	IN	0
loss	loss	NN	0
of	of	IN	0
Arp2	Arp2	CD	B-NP
/	/	CD	0
3	3	CD	0
complex	complex	JJ	0
localization	localization	NN	B-NP
,	,	,	0
we	we	PRP	0
generated	generated	VBD	0
a	a	DT	0
stable	stable	JJ	0
cell	cell	NN	0
line	line	NN	0
expressing	expressing	VBG	B-NP
Arp3-GFP	Arp3-GFP	CD	I-NP
.	.	.	0
After	After	IN	0
BDM	BDM	NNP	B-NP
treatment	treatment	NN	I-NP
,	,	,	0
we	we	PRP	0
observed	observed	VBD	0
a	a	DT	0
uniform	uniform	JJ	0
decrease	decrease	NN	0
in	in	IN	0
fluorescence	fluorescence	JJ	0
suggestive	suggestive	NN	0
of	of	IN	0
dissociation	dissociation	NN	B-NP
and	and	CC	0
diffusion	diffusion	NN	0
of	of	IN	0
Arp3	Arp3	NNP	B-NP
,	,	,	0
rather	rather	RB	0
than	than	IN	0
de-localization	de-localization	JJ	B-NP
driven	driven	VBN	0
by	by	IN	0
retrograde	retrograde	JJ	0
flow	flow	NN	0
[	[	-LRB-	0
Figure	Figure	NNP	0
5A	5A	NNP	0
]	]	-RRB-	0
.	.	.	0
A	A	DT	0
linescan	linescan	NN	B-NP
of	of	IN	0
the	the	DT	0
leading	leading	JJ	0
edge	edge	NN	0
shown	shown	VBN	0
in	in	IN	0
Figure	Figure	NNP	0
5A	5A	NNP	0
,	,	,	0
plotted	plotted	VBD	0
across	across	IN	0
time	time	NN	0
shows	shows	VBZ	0
the	the	DT	0
pattern	pattern	NN	0
and	and	CC	0
extent	extent	NN	0
of	of	IN	0
loss	loss	NN	0
of	of	IN	0
fluorescence	fluorescence	JJ	B-NP
signal	signal	NN	I-NP
[	[	-LRB-	0
Figure	Figure	NNP	0
5B	5B	NNP	0
]	]	-RRB-	0
.	.	.	0
fluorescence	fluorescence	NN	B-NP
level	level	JJ	I-NP
decrease	decrease	VBP	0
gradually	gradually	RB	0
with	with	IN	0
little	little	JJ	0
or	or	CC	0
no	no	DT	0
shift	shift	NN	0
in	in	IN	0
the	the	DT	0
peak	peak	NN	0
of	of	IN	0
fluorescence	fluorescence	JJ	0
backward	backward	NN	0
.	.	.	0
By	By	IN	0
two	two	CD	0
minutes	minutes	NNS	0
,	,	,	0
fluorescence	fluorescence	JJ	B-NP
level	level	JJ	I-NP
at	at	IN	0
the	the	DT	0
leading	leading	JJ	0
edge	edge	NN	0
are	are	VBP	0
equivalent	equivalent	JJ	0
to	to	TO	0
background	background	NN	0
.	.	.	0
After	After	IN	0
washout	washout	NN	0
of	of	IN	0
butanedione	butanedione	NN	B-NP
monoxime	monoxime	NN	I-NP
,	,	,	0
arp3-gfp	arp3-gfp	NN	B-NP
localization	localization	CD	I-NP
return	return	NN	I-NP
in	in	IN	0
just	just	RB	0
over	over	IN	0
one	one	CD	0
minute	minute	NN	0
.	.	.	0
In	In	IN	0
all	all	DT	0
cases	cases	NNS	0
,	,	,	0
the	the	DT	0
loss	loss	NN	0
of	of	IN	0
Arp3-GFP	Arp3-GFP	CD	B-NP
at	at	IN	0
the	the	DT	0
leading	leading	JJ	0
edge	edge	NN	0
was	was	VBD	0
seen	seen	VBN	0
concomitantly	concomitantly	RB	0
with	with	IN	0
loss	loss	NN	0
of	of	IN	0
ruffling	ruffling	NN	0
and	and	CC	0
retraction	retraction	NN	0
of	of	IN	0
the	the	DT	0
leading	leading	JJ	0
edge	edge	NN	0
or	or	CC	0
as	as	IN	0
de-localization	de-localization	JJ	B-NP
with	with	IN	0
slight	slight	JJ	0
retraction	retraction	NN	0
.	.	.	0
We	We	PRP	0
did	did	VBD	0
not	not	RB	0
see	see	VB	0
retrograde	retrograde	JJ	0
flow	flow	NN	0
of	of	IN	0
the	the	DT	0
Arp3	Arp3	JJ	B-NP
signal	signal	NN	I-NP
in	in	IN	0
an	an	DT	0
otherwise	otherwise	RB	0
stable	stable	JJ	0
leading	leading	JJ	0
edge	edge	NN	0
.	.	.	0
Discussion	Discussion	NNP	B-NP
BDM	BDM	NNP	I-NP
has	has	VBZ	0
been	been	VBN	0
used	used	VBN	0
to	to	TO	0
probe	probe	VB	0
actin-dependent	actin-dependent	JJ	B-NP
process	process	NN	I-NP
on	on	IN	0
the	the	DT	0
assumption	assumption	NN	0
that	that	IN	0
it	it	PRP	0
is	is	VBZ	0
a	a	DT	0
specific	specific	JJ	0
inhibitor	inhibitor	NN	0
of	of	IN	0
mysosin	mysosin	NN	B-NP
.	.	.	0
butanedione	butanedione	NN	B-NP
monoxime	monoxime	NN	I-NP
has	has	VBZ	0
recently	recently	RB	0
been	been	VBN	0
found	found	VBN	0
not	not	RB	0
to	to	TO	0
inhibit	inhibit	VB	0
the	the	DT	0
in	in	IN	0
vitro	vitro	JJ	B-NP
ATPase	ATPase	JJ	I-NP
activity	activity	NN	I-NP
of	of	IN	0
human	human	JJ	0
platelet	platelet	JJ	B-NP
nm-myosinII	nm-myosinII	NN	I-NP
,	,	,	0
Acanthamoeba	Acanthamoeba	NNP	B-NP
myosinIc	myosinIc	NNP	I-NP
,	,	,	0
human	human	JJ	0
myoIe	myoIe	NN	B-NP
,	,	,	0
chicken	chicken	NN	B-NP
myosinV	myosinV	NN	I-NP
,	,	,	0
and	and	CC	0
porcine	porcine	JJ	B-NP
myosinVI	myosinVI	NN	I-NP
,	,	,	0
though	though	IN	0
it	it	PRP	0
does	does	VBZ	0
inhibit	inhibit	FW	0
rabbit	rabbit	NN	B-NP
muscle	muscle	NN	I-NP
myosinII	myosinII	NN	I-NP
[	[	-LRB-	0
9	9	CD	0
10	10	CD	0
]	]	-RRB-	0
.	.	.	0
Thus	Thus	RB	0
the	the	DT	0
literature	literature	NN	0
's	's	POS	0
interpretation	interpretation	NN	B-NP
of	of	IN	0
BDM	BDM	NNP	0
's	's	POS	0
effects	effects	NNS	0
are	are	VBP	0
probably	probably	RB	0
incorrect	incorrect	JJ	0
.	.	.	0
Our	Our	PRP$	0
results	results	NNS	0
suggest	suggest	VBP	0
that	that	IN	0
the	the	DT	0
effects	effects	NNS	0
of	of	IN	0
butanedione	butanedione	NN	B-NP
monoxime	monoxime	NN	I-NP
on	on	IN	0
actin-dependent	actin-dependent	JJ	B-NP
process	process	NN	I-NP
such	such	JJ	0
as	as	IN	0
cell	cell	NN	B-NP
motility	motility	NN	I-NP
and	and	CC	0
retrograde	retrograde	JJ	0
flow	flow	NN	0
may	may	MD	0
result	result	VB	0
from	from	IN	0
effects	effects	NNS	0
on	on	IN	0
proteins	proteins	NNS	0
involved	involved	VBN	0
in	in	IN	0
actin	actin	JJ	B-NP
polymerization	polymerization	NN	I-NP
and	and	CC	0
the	the	DT	0
leading	leading	JJ	0
edge	edge	NN	0
actin	actin	VBD	0
itself	itself	PRP	0
.	.	.	0
It	It	PRP	0
is	is	VBZ	0
not	not	RB	0
clear	clear	JJ	0
if	if	IN	0
these	these	DT	0
effects	effects	NNS	0
on	on	IN	0
leading	leading	VBG	B-NP
edge	edge	NN	I-NP
component	component	JJ	I-NP
are	are	VBP	0
direct	direct	JJ	0
or	or	CC	0
indirect	indirect	JJ	0
.	.	.	0
The	The	DT	0
loss	loss	NN	0
of	of	IN	0
actin	actin	JJ	B-NP
polymerization	polymerization	JJ	I-NP
machinery	machinery	NN	I-NP
,	,	,	0
however	however	RB	0
,	,	,	0
is	is	VBZ	0
a	a	DT	0
previously	previously	RB	0
bdm	bdm	NN	B-NP
treatment	treatment	NN	I-NP
un-described	un-described	JJ	I-NP
effect	effect	NN	I-NP
and	and	CC	0
this	this	DT	0
highlights	highlights	VBZ	0
the	the	DT	0
importance	importance	NN	0
of	of	IN	0
defining	defining	VBG	0
the	the	DT	0
localization	localization	NN	B-NP
of	of	IN	0
proteins	proteins	NNS	0
involved	involved	VBN	0
in	in	IN	0
actin	actin	JJ	B-NP
dynamic	dynamic	JJ	I-NP
when	when	WRB	0
leading	leading	JJ	0
edge	edge	NN	B-NP
activity	activity	NN	I-NP
is	is	VBZ	0
disrupted	disrupted	VBN	0
.	.	.	0
BDM	BDM	NNP	B-NP
application	application	NN	I-NP
leads	leads	VBZ	0
to	to	TO	0
the	the	DT	0
loss	loss	NN	0
of	of	IN	0
leading	leading	VBG	B-NP
edge	edge	NN	I-NP
component	component	JJ	I-NP
localization	localization	NN	I-NP
involved	involved	VBN	0
in	in	IN	0
actin	actin	JJ	B-NP
nucleation	nucleation	NN	I-NP
.	.	.	0
We	We	PRP	0
observe	observe	VBP	0
that	that	IN	0
within	within	IN	0
two	two	CD	0
minutes	minutes	NNS	0
,	,	,	0
application	application	NN	0
of	of	IN	0
butanedione	butanedione	NN	B-NP
monoxime	monoxime	NN	I-NP
leads	leads	VBZ	0
to	to	TO	0
the	the	DT	0
de-localization	de-localization	JJ	B-NP
of	of	IN	0
the	the	DT	0
leading	leading	JJ	0
edge	edge	NN	B-NP
component	component	JJ	I-NP
-	-	:	0
Arp3	Arp3	CD	B-NP
,	,	,	0
VASP	VASP	NNP	B-NP
,	,	,	0
and	and	CC	0
WAVE	WAVE	NNP	0
-	-	:	0
and	and	CC	0
this	this	DT	0
is	is	VBZ	0
concurrent	concurrent	VBN	0
with	with	IN	0
the	the	DT	0
loss	loss	NN	0
of	of	IN	0
the	the	DT	0
actin	actin	JJ	B-NP
network	network	NN	I-NP
at	at	IN	0
the	the	DT	0
leading	leading	JJ	0
edge	edge	NN	0
.	.	.	0
Our	Our	PRP$	0
data	data	NNS	0
suggest	suggest	VBP	0
a	a	DT	0
mechanism	mechanism	NN	0
of	of	IN	0
arp3	arp3	NN	B-NP
de-localization	de-localization	JJ	I-NP
consistent	consistent	JJ	0
with	with	IN	0
dissociation	dissociation	NN	B-NP
or	or	CC	0
diffusion	diffusion	VBP	0
rather	rather	RB	0
than	than	IN	0
retrograde	retrograde	JJ	0
flow	flow	NN	0
.	.	.	0
We	We	PRP	0
cannot	cannot	RB	0
determine	determine	VB	0
the	the	DT	0
causal	causal	JJ	B-NP
relationship	relationship	NN	I-NP
between	between	IN	0
loss	loss	NN	0
of	of	IN	0
leading	leading	VBG	B-NP
edge	edge	NN	I-NP
component	component	JJ	I-NP
and	and	CC	0
loss	loss	NN	0
of	of	IN	0
the	the	DT	0
leading	leading	JJ	0
edge	edge	NN	B-NP
actin	actin	NN	I-NP
network	network	NN	I-NP
itself	itself	PRP	0
.	.	.	0
At	At	IN	0
the	the	DT	0
least	least	JJS	0
,	,	,	0
the	the	DT	0
two	two	CD	0
occur	occur	VBP	0
simultaneously	simultaneously	RB	0
.	.	.	0
Interestingly	Interestingly	RB	0
,	,	,	0
listeria	listeria	NN	B-NP
bacterium	bacterium	NN	I-NP
continue	continue	VBP	0
to	to	TO	0
move	move	VB	0
in	in	IN	0
the	the	DT	0
presence	presence	NN	0
of	of	IN	0
butanedione	butanedione	NN	B-NP
monoxime	monoxime	NN	I-NP
,	,	,	0
while	while	IN	0
the	the	DT	0
leading	leading	JJ	0
edge	edge	NN	0
of	of	IN	0
the	the	DT	0
infected	infected	JJ	0
cell	cell	NN	0
stops	stops	VBZ	0
ruffling	ruffling	VBN	0
.	.	.	0
Both	Both	DT	0
processes	processes	NNS	0
have	have	VBP	0
been	been	VBN	0
shown	shown	VBN	0
to	to	TO	0
involve	involve	VB	0
the	the	DT	0
Arp2	Arp2	CD	B-NP
/	/	CD	0
3	3	CD	0
complex	complex	NN	0
.	.	.	0
That	That	IN	0
butanedione	butanedione	NN	B-NP
monoxime	monoxime	NN	I-NP
inhibits	inhibits	VBD	0
one	one	CD	0
actin	actin	CD	B-NP
dependent	dependent	JJ	0
process	process	NN	0
but	but	CC	0
not	not	RB	0
the	the	DT	0
other	other	JJ	0
,	,	,	0
may	may	MD	0
be	be	VB	0
an	an	DT	0
interesting	interesting	JJ	0
difference	difference	NN	0
in	in	IN	0
the	the	DT	0
location	location	NN	0
of	of	IN	0
polymerization	polymerization	NN	B-NP
within	within	IN	0
the	the	DT	0
cell	cell	NN	0
-	-	:	0
actin	actin	JJ	B-NP
polymerization	polymerization	NN	I-NP
at	at	IN	0
the	the	DT	0
leading	leading	JJ	0
edge	edge	NN	0
vs.	vs.	IN	0
the	the	DT	0
cell	cell	NN	0
body	body	NN	0
,	,	,	0
or	or	CC	0
a	a	DT	0
difference	difference	NN	0
in	in	IN	0
the	the	DT	0
mechanism	mechanism	NN	0
of	of	IN	0
actin	actin	JJ	B-NP
polymerization	polymerization	NN	I-NP
-	-	:	0
the	the	DT	0
leading	leading	JJ	0
edge	edge	NN	0
vs.	vs.	IN	0
a	a	DT	0
Listeria	Listeria	JJ	B-NP
bacterium	bacterium	NN	I-NP
.	.	.	0
BDM	BDM	NNP	B-NP
treatment	treatment	NN	I-NP
thus	thus	RB	0
seems	seems	VBZ	0
to	to	TO	0
disrupt	disrupt	VB	0
actin	actin	JJ	B-NP
dynamic	dynamic	JJ	I-NP
specific	specific	JJ	0
to	to	TO	0
the	the	DT	0
plasma	plasma	JJ	0
membrane	membrane	NN	0
and	and	CC	0
this	this	DT	0
may	may	MD	0
provide	provide	VB	0
a	a	DT	0
clue	clue	NN	0
to	to	TO	0
both	both	PDT	0
the	the	DT	0
mechanism	mechanism	NN	0
of	of	IN	0
BDM	BDM	NNP	B-NP
inhibition	inhibition	NN	I-NP
and	and	CC	0
the	the	DT	0
actin	actin	JJ	B-NP
dynamic	dynamic	JJ	I-NP
relationship	relationship	NN	I-NP
at	at	IN	0
the	the	DT	0
plasma	plasma	JJ	0
membrane	membrane	NN	0
.	.	.	0
Current	Current	JJ	B-NP
understanding	understanding	NN	I-NP
of	of	IN	0
the	the	DT	0
retrograde	retrograde	JJ	0
flow	flow	NN	0
of	of	IN	0
actin	actin	NN	B-NP
has	has	VBZ	0
been	been	VBN	0
influenced	influenced	VBN	0
by	by	IN	0
the	the	DT	0
use	use	NN	0
of	of	IN	0
butanedione	butanedione	NN	B-NP
monoxime	monoxime	NN	I-NP
in	in	IN	0
the	the	DT	0
sea	sea	NN	B-NP
urchin	urchin	NN	I-NP
coelomocyta	coelomocyta	NN	I-NP
and	and	CC	0
aplysia	aplysia	NN	B-NP
bag	bag	NN	I-NP
cell	cell	NN	I-NP
neuron	neuron	NN	I-NP
system	system	NN	I-NP
.	.	.	0
Our	Our	PRP$	0
data	data	NNS	0
are	are	VBP	0
consistent	consistent	JJ	0
with	with	IN	0
results	results	NNS	0
in	in	IN	0
sea	sea	NN	B-NP
urchin	urchin	NN	I-NP
coelomocyte	coelomocyte	NN	I-NP
where	where	WRB	0
butanedione	butanedione	NN	B-NP
monoxime	monoxime	NN	I-NP
phenocopies	phenocopies	VBD	0
the	the	DT	0
effect	effect	NN	0
of	of	IN	0
cytochalasin	cytochalasin	JJ	0
D	D	NNP	0
,	,	,	0
blocking	blocking	VBG	0
retrograde	retrograde	JJ	0
flow	flow	NN	0
at	at	IN	0
the	the	DT	0
leading	leading	JJ	0
edge	edge	NN	0
with	with	IN	0
continued	continued	JJ	0
actin	actin	JJ	B-NP
network	network	NN	I-NP
contraction	contraction	NN	I-NP
causing	causing	VBG	0
a	a	DT	0
clearing	clearing	NN	0
of	of	IN	0
actin	actin	NN	B-NP
at	at	IN	0
the	the	DT	0
leading	leading	JJ	0
edge	edge	NN	0
[	[	-LRB-	0
11	11	CD	0
]	]	-RRB-	0
.	.	.	0
In	In	IN	0
the	the	DT	0
coelomyocte	coelomyocte	JJ	B-NP
system	system	NN	I-NP
,	,	,	0
leading	leading	VBG	B-NP
edge	edge	NN	I-NP
component	component	JJ	I-NP
de-localization	de-localization	JJ	I-NP
by	by	IN	0
butanedione	butanedione	NN	B-NP
monoxime	monoxime	NN	I-NP
could	could	MD	0
account	account	VB	0
for	for	IN	0
the	the	DT	0
inhibition	inhibition	NN	0
of	of	IN	0
actin	actin	JJ	B-NP
polymerization	polymerization	NN	I-NP
and	and	CC	0
clearing	clearing	NN	0
.	.	.	0
In	In	IN	0
the	the	DT	0
Aplysia	Aplysia	JJ	B-NP
bag	bag	NN	I-NP
cell	cell	NN	I-NP
neuron	neuron	NN	I-NP
,	,	,	0
BDM	BDM	NNP	B-NP
application	application	NN	I-NP
leads	leads	VBZ	0
to	to	TO	0
extension	extension	NN	0
of	of	IN	0
filopodia	filopodia	NN	B-NP
and	and	CC	0
the	the	DT	0
growth	growth	NN	B-NP
cone	cone	VBD	0
itself	itself	PRP	0
.	.	.	0
Filopodial	Filopodial	JJ	B-NP
extension	extension	NN	I-NP
was	was	VBD	0
interpreted	interpreted	VBN	0
as	as	IN	0
supporting	supporting	VBG	0
the	the	DT	0
clutch	clutch	JJ	0
model	model	NN	0
,	,	,	0
with	with	IN	0
pulling	pulling	VBG	B-NP
filament	filament	NN	I-NP
myosin	myosin	NN	I-NP
toward	toward	IN	0
the	the	DT	0
growth	growth	NN	B-NP
cone	cone	NN	I-NP
interior	interior	NN	I-NP
.	.	.	0
When	When	WRB	0
the	the	DT	0
myosin	myosin	JJ	B-NP
activity	activity	NN	I-NP
was	was	VBD	0
blocked	blocked	VBN	0
with	with	IN	0
BDM	BDM	NNP	B-NP
treatment	treatment	NN	I-NP
,	,	,	0
continued	continued	VBD	0
actin	actin	JJ	B-NP
polymerization	polymerization	NN	I-NP
,	,	,	0
thought	thought	VBD	0
to	to	TO	0
occur	occur	VB	0
as	as	IN	0
elongation	elongation	NN	0
of	of	IN	0
existing	existing	VBG	0
filaments	filaments	NN	0
,	,	,	0
lead	lead	NN	0
to	to	TO	0
protrusion	protrusion	VB	0
[	[	-LRB-	0
12	12	CD	0
27	27	CD	0
28	28	CD	0
]	]	-RRB-	0
.	.	.	0
Our	Our	PRP$	0
observation	observation	NN	0
of	of	IN	0
BDM	BDM	NNP	B-NP
activity	activity	NN	I-NP
suggests	suggests	VBZ	0
an	an	DT	0
alternative	alternative	JJ	0
explanation	explanation	NN	0
.	.	.	0
Perhaps	Perhaps	RB	0
components	components	VB	0
required	required	VBN	0
for	for	IN	0
nucleation	nucleation	NN	B-NP
are	are	VBP	0
de-localized	de-localized	JJ	B-NP
by	by	IN	0
butanedione	butanedione	NN	B-NP
monoxime	monoxime	NN	I-NP
allowing	allowing	VBG	0
new	new	JJ	0
polymerization	polymerization	NN	B-NP
to	to	TO	0
be	be	VB	0
re-directed	re-directed	JJ	0
to	to	TO	0
filopodia	filopodia	VB	0
,	,	,	0
as	as	IN	0
filopodial	filopodial	JJ	B-NP
extension	extension	NN	I-NP
is	is	VBZ	0
thought	thought	VBN	0
to	to	TO	0
be	be	VB	0
driven	driven	VBN	0
by	by	IN	0
elongation	elongation	NN	0
and	and	CC	0
not	not	RB	0
nucleation	nucleation	JJ	0
[	[	-LRB-	0
27	27	CD	0
]	]	-RRB-	0
.	.	.	0
The	The	DT	0
extension	extension	NN	0
of	of	IN	0
the	the	DT	0
growth	growth	NN	B-NP
cone	cone	VBD	0
itself	itself	PRP	0
could	could	MD	0
result	result	VB	0
from	from	IN	0
a	a	DT	0
similar	similar	JJ	0
diversion	diversion	NN	0
of	of	IN	0
actin	actin	JJ	B-NP
monomer	monomer	NN	I-NP
from	from	IN	0
nucleation	nucleation	NN	B-NP
of	of	IN	0
new	new	JJ	0
filaments	filaments	NN	0
to	to	TO	0
extension	extension	NN	0
of	of	IN	0
existing	existing	VBG	0
filaments	filaments	NNS	0
.	.	.	0
Treatment	Treatment	NN	0
of	of	IN	0
cells	cells	NNS	0
with	with	IN	0
butanedione	butanedione	NN	B-NP
monoxime	monoxime	NN	I-NP
often	often	RB	0
leads	leads	VBZ	0
to	to	TO	0
filopodia-like	filopodia-like	JJ	B-NP
projection	projection	NN	I-NP
as	as	RB	0
seen	seen	VBN	0
in	in	IN	0
Figure	Figure	NNP	0
1Band	1Band	NNP	0
Figure	Figure	NNP	0
2B	2B	NNP	0
.	.	.	0
Data	Data	NNS	0
from	from	IN	0
studies	studies	NNS	0
of	of	IN	0
in	in	IN	0
vivo	vivo	NN	B-NP
and	and	CC	0
in	in	IN	0
vitro	vitro	JJ	B-NP
filopodia	filopodia	JJ	I-NP
formation	formation	NN	I-NP
suggest	suggest	VBP	0
that	that	IN	0
they	they	PRP	0
develop	develop	VBP	0
as	as	IN	0
a	a	DT	0
dendritic	dendritic	JJ	B-NP
network	network	NN	I-NP
reorganization	reorganization	NN	I-NP
in	in	IN	0
which	which	WDT	0
they	they	PRP	0
exist	exist	VBP	0
[	[	-LRB-	0
29	29	CD	0
30	30	CD	0
]	]	-RRB-	0
.	.	.	0
In	In	IN	0
the	the	DT	0
presence	presence	NN	0
of	of	IN	0
proteins	proteins	NNS	0
that	that	IN	0
bundle	bundle	NN	0
and	and	CC	0
reorganize	reorganize	VB	0
actin	actin	JJ	B-NP
filament	filament	NN	I-NP
into	into	IN	0
filopodial	filopodial	JJ	B-NP
precursor	precursor	NN	I-NP
,	,	,	0
the	the	DT	0
arp2	arp2	NN	B-NP
de-localization	de-localization	JJ	I-NP
/	/	CD	0
3	3	CD	0
and	and	CC	0
other	other	JJ	0
leading	leading	JJ	0
edge	edge	NN	B-NP
component	component	JJ	I-NP
may	may	MD	0
lead	lead	VB	0
to	to	TO	0
the	the	DT	0
formation	formation	NN	0
of	of	IN	0
filopodia	filopodia	NN	B-NP
,	,	,	0
which	which	WDT	0
are	are	VBP	0
then	then	RB	0
elongated	elongated	VBN	0
as	as	RB	0
described	described	VBN	0
above	above	IN	0
.	.	.	0
Future	Future	JJ	0
studies	studies	NNS	0
will	will	MD	0
hopefully	hopefully	RB	0
clarify	clarify	VB	0
the	the	DT	0
role	role	NN	0
of	of	IN	0
actin	actin	JJ	B-NP
nucleation	nucleation	NN	I-NP
in	in	IN	0
the	the	DT	0
Aplysia	Aplysia	JJ	B-NP
system	system	NN	I-NP
or	or	CC	0
alternative	alternative	JJ	0
mechanisms	mechanisms	NNS	0
that	that	WDT	0
would	would	MD	0
reconcile	reconcile	VB	0
the	the	DT	0
discrepancy	discrepancy	NN	B-NP
between	between	IN	0
systems	systems	NNS	0
.	.	.	0
In	In	IN	0
all	all	DT	0
systems	systems	NNS	0
,	,	,	0
a	a	DT	0
better	better	JJR	0
understanding	understanding	NN	0
of	of	IN	0
how	how	WRB	0
the	the	DT	0
leading	leading	JJ	0
edge	edge	NN	0
is	is	VBZ	0
constructed	constructed	VBN	0
and	and	CC	0
maintained	maintained	VBN	0
will	will	MD	0
require	require	VB	0
specific	specific	JJ	0
and	and	CC	0
detailed	detailed	JJ	0
description	description	NN	B-NP
of	of	IN	0
the	the	DT	0
activity	activity	NN	0
and	and	CC	0
localization	localization	NN	B-NP
of	of	IN	0
the	the	DT	0
proteins	proteins	NNS	0
involved	involved	VBN	0
.	.	.	0
Membrane	Membrane	JJ	0
ruffling	ruffling	NN	0
,	,	,	0
often	often	RB	0
used	used	VBN	0
as	as	IN	0
a	a	DT	0
measure	measure	NN	0
of	of	IN	0
actin	actin	JJ	B-NP
dynamic	dynamic	JJ	I-NP
at	at	IN	0
the	the	DT	0
leading	leading	JJ	0
edge	edge	NN	0
,	,	,	0
is	is	VBZ	0
a	a	DT	0
very	very	RB	0
crude	crude	JJ	0
readout	readout	NN	B-NP
.	.	.	0
The	The	DT	0
sensitivity	sensitivity	NN	0
of	of	IN	0
the	the	DT	0
leading	leading	JJ	0
edge	edge	NN	0
is	is	VBZ	0
demonstrated	demonstrated	VBN	0
by	by	IN	0
the	the	DT	0
observation	observation	NN	0
that	that	IN	0
DMSO	DMSO	NNP	B-NP
treatment	treatment	NN	I-NP
at	at	IN	0
a	a	DT	0
concentration	concentration	NN	B-NP
of	of	IN	0
1	1	CD	0
%	%	NN	0
causes	causes	VBZ	0
temporary	temporary	JJ	B-NP
inhibition	inhibition	NN	I-NP
of	of	IN	0
ruffling	ruffling	NN	0
and	and	CC	0
concomitant	concomitant	JJ	0
Arp3	Arp3	NNP	B-NP
de-localization	de-localization	NNP	I-NP
(	(	-LRB-	0
Yarrow	Yarrow	NNP	0
unpublished	unpublished	JJ	0
results	results	NNS	0
)	)	-RRB-	0
.	.	.	0
experimental	experimental	JJ	B-NP
approach	approach	NN	I-NP
that	that	WDT	0
may	may	MD	0
help	help	VB	0
address	address	VB	0
how	how	WRB	0
such	such	PDT	0
a	a	DT	0
dynamic	dynamic	JJ	0
and	and	CC	0
sensitive	sensitive	JJ	B-NP
structure	structure	NN	I-NP
is	is	VBZ	0
established	established	VBN	0
and	and	CC	0
maintained	maintained	NNS	0
include	include	VBP	0
combining	combining	VBG	0
inhibition	inhibition	NN	0
of	of	IN	0
actin	actin	JJ	B-NP
dynamic	dynamic	JJ	I-NP
with	with	IN	0
the	the	DT	0
use	use	NN	0
of	of	IN	0
tools	tools	NNS	0
that	that	WDT	0
affect	affect	VBP	0
Arp2	Arp2	CD	B-NP
/	/	CD	0
3	3	CD	0
or	or	CC	0
myosin	myosin	JJ	B-NP
activity	activity	NN	I-NP
or	or	CC	0
localization	localization	NN	B-NP
,	,	,	0
in	in	IN	0
specific	specific	JJ	0
ways	ways	NNS	0
.	.	.	0
Though	Though	IN	0
preliminary	preliminary	JJ	0
,	,	,	0
we	we	PRP	0
have	have	VBP	0
seen	seen	VBN	0
that	that	IN	0
Arp3	Arp3	NNP	B-NP
is	is	VBZ	0
still	still	RB	0
localized	localized	VBN	0
in	in	IN	0
the	the	DT	0
presence	presence	NN	0
of	of	IN	0
latrunculin	latrunculin	JJ	0
A	A	NN	0
and	and	CC	0
jasplakinolide	jasplakinolide	NN	B-NP
,	,	,	0
and	and	CC	0
that	that	IN	0
this	this	DT	0
localization	localization	NN	B-NP
is	is	VBZ	0
lost	lost	VBN	0
with	with	IN	0
BDM	BDM	NNP	B-NP
treatment	treatment	NN	I-NP
unlike	unlike	IN	0
the	the	DT	0
combination	combination	NN	0
of	of	IN	0
cytochalasin	cytochalasin	JJ	0
D	D	NNP	0
and	and	CC	0
butanedione	butanedione	NN	B-NP
monoxime	monoxime	NN	I-NP
(	(	-LRB-	0
Yarrow	Yarrow	NNP	0
unpublished	unpublished	JJ	0
results	results	NNS	0
)	)	-RRB-	0
.	.	.	0
These	These	DT	0
results	results	NNS	0
may	may	MD	0
in	in	IN	0
the	the	DT	0
end	end	NN	0
tell	tell	VBP	0
us	us	PRP	0
more	more	RBR	0
about	about	IN	0
our	our	PRP$	0
understanding	understanding	NN	0
of	of	IN	0
what	what	WP	0
latrunculin	latrunculin	VBD	0
A	A	DT	0
and	and	CC	0
jasplakinolida	jasplakinolida	NN	B-NP
do	do	VBP	0
in	in	IN	0
vivo	vivo	NN	B-NP
than	than	IN	0
the	the	DT	0
leading	leading	JJ	0
edge	edge	NN	0
itself	itself	PRP	0
.	.	.	0
Regardless	Regardless	RB	0
,	,	,	0
this	this	DT	0
type	type	NN	0
of	of	IN	0
experiment	experiment	NN	0
awaits	awaits	VBZ	0
more	more	RBR	0
specific	specific	JJ	0
tools	tools	NNS	0
than	than	IN	0
butanedione	butanedione	NN	B-NP
monoxime	monoxime	NN	I-NP
for	for	IN	0
follow	follow	VB	0
up	up	RP	0
.	.	.	0
Though	Though	IN	0
butanedione	butanedione	NN	B-NP
monoxime	monoxime	NN	I-NP
has	has	VBZ	0
a	a	DT	0
relatively	relatively	RB	0
high	high	JJ	0
effective	effective	JJ	0
concentration	concentration	NN	B-NP
(	(	-LRB-	0
in	in	IN	0
the	the	DT	0
millimolar	millimolar	JJ	B-NP
range	range	NN	I-NP
)	)	-RRB-	0
,	,	,	0
it	it	PRP	0
was	was	VBD	0
widely	widely	RB	0
adopted	adopted	VBN	0
by	by	IN	0
the	the	DT	0
cell	cell	NN	0
biology	biology	NN	0
community	community	NN	0
because	because	IN	0
of	of	IN	0
its	its	PRP$	0
rapid	rapid	JJ	0
and	and	CC	0
reversible	reversible	JJ	0
effect	effect	NN	0
on	on	IN	0
cell	cell	NN	0
behaviour	behaviour	NN	0
.	.	.	0
butanedione	butanedione	NN	B-NP
monoxime	monoxime	NN	I-NP
has	has	VBZ	0
not	not	RB	0
been	been	VBN	0
exhaustively	exhaustively	RB	0
tested	tested	VBN	0
on	on	IN	0
all	all	DT	0
myosin	myosin	NN	B-NP
,	,	,	0
and	and	CC	0
a	a	DT	0
myosin	myosin	JJ	B-NP
target	target	NN	I-NP
is	is	VBZ	0
not	not	RB	0
unreasonable	unreasonable	VB	0
given	given	VBN	0
findings	findings	NNS	0
in	in	IN	0
Acanthomoeba	Acanthomoeba	NNP	B-NP
and	and	CC	0
S.	S.	NNP	B-NP
cerviseae	cerviseae	NN	I-NP
though	though	IN	0
it	it	PRP	0
does	does	VBZ	0
not	not	RB	0
inhibit	inhibit	VB	0
Acanthamoeba	Acanthamoeba	NNP	B-NP
myosinIc	myosinIc	NNP	I-NP
or	or	CC	0
human	human	JJ	0
myoIe	myoIe	NN	B-NP
in	in	IN	0
vitro	vitro	NN	B-NP
[	[	-LRB-	0
10	10	CD	0
20	20	CD	0
21	21	CD	0
31	31	CD	0
]	]	-RRB-	0
.	.	.	0
Regardless	Regardless	RB	0
,	,	,	0
we	we	PRP	0
and	and	CC	0
others	others	NNS	0
have	have	VBP	0
shown	shown	VBN	0
that	that	IN	0
butanedione	butanedione	NN	B-NP
monoxime	monoxime	NN	I-NP
is	is	VBZ	0
not	not	RB	0
the	the	DT	0
tool	tool	NN	0
that	that	WDT	0
should	should	MD	0
be	be	VB	0
used	used	VBN	0
to	to	TO	0
investigate	investigate	VB	0
these	these	DT	0
behaviours	behaviours	NN	0
.	.	.	0
The	The	DT	0
small	small	JJ	0
molecule	molecule	NN	B-NP
approach	approach	NN	I-NP
continues	continues	VBZ	0
to	to	TO	0
be	be	VB	0
an	an	DT	0
effective	effective	JJ	0
means	means	NNS	0
to	to	TO	0
develop	develop	VB	0
tools	tools	NNS	0
for	for	IN	0
biological	biological	JJ	B-NP
process	process	NN	I-NP
understanding	understanding	VBG	I-NP
cell	cell	NN	I-NP
when	when	WRB	0
used	used	VBN	0
and	and	CC	0
interpreted	interpreted	VBD	0
appropriately	appropriately	RB	0
.	.	.	0
One	One	CD	0
new	new	JJ	0
compound	compound	NN	B-NP
that	that	WDT	0
will	will	MD	0
help	help	VB	0
clarify	clarify	VB	0
the	the	DT	0
role	role	NN	0
of	of	IN	0
nm-myosinII	nm-myosinII	NNP	B-NP
is	is	VBZ	0
blebbistatin	blebbistatin	JJ	0
[	[	-LRB-	0
32	32	CD	0
]	]	-RRB-	0
.	.	.	0
Other	Other	JJ	0
small	small	JJ	0
molecules	molecules	NNS	0
wait	wait	VBP	0
to	to	TO	0
be	be	VB	0
found	found	VBN	0
and	and	CC	0
experiments	experiments	NNS	0
using	using	VBG	0
them	them	PRP	0
will	will	MD	0
continuously	continuously	RB	0
refine	refine	VB	0
our	our	PRP$	0
understanding	understanding	NN	0
of	of	IN	0
the	the	DT	0
leading	leading	JJ	0
edge	edge	NN	0
and	and	CC	0
the	the	DT	0
mechanism	mechanism	NN	0
of	of	IN	0
action	action	NN	0
of	of	IN	0
these	these	DT	0
compounds	compounds	NN	0
.	.	.	0
Conclusions	Conclusions	NNS	0
actin	actin	JJ	B-NP
leading	leading	JJ	I-NP
edge	edge	NN	I-NP
component	component	JJ	I-NP
de-localization	de-localization	NN	I-NP
by	by	IN	0
BDM	BDM	NNP	B-NP
treatment	treatment	NN	I-NP
is	is	VBZ	0
a	a	DT	0
newly	newly	RB	0
described	described	VBN	0
effect	effect	NN	0
of	of	IN	0
this	this	DT	0
compound	compound	NN	B-NP
.	.	.	0
It	It	PRP	0
may	may	MD	0
explain	explain	VB	0
results	results	NNS	0
previously	previously	RB	0
ascribed	ascribed	VBN	0
to	to	TO	0
inhibition	inhibition	VB	0
of	of	IN	0
non-muscle	non-muscle	JJ	B-NP
myosinII	myosinII	NN	I-NP
by	by	IN	0
butanedione	butanedione	NN	B-NP
monoxime	monoxime	NN	I-NP
,	,	,	0
particularly	particularly	RB	0
in	in	IN	0
retrograde	retrograde	JJ	0
flow	flow	NN	B-NP
study	study	NN	I-NP
.	.	.	0
Though	Though	IN	0
this	this	DT	0
effect	effect	NN	0
of	of	IN	0
butanedione	butanedione	NN	B-NP
monoxime	monoxime	NN	I-NP
is	is	VBZ	0
intriguing	intriguing	JJ	0
,	,	,	0
future	future	JJ	0
studies	studies	NNS	0
that	that	WDT	0
look	look	VBP	0
at	at	IN	0
the	the	DT	0
establishment	establishment	NN	B-NP
and	and	CC	0
maintenance	maintenance	NN	0
of	of	IN	0
the	the	DT	0
actin	actin	JJ	B-NP
leading	leading	JJ	I-NP
edge	edge	NN	I-NP
should	should	MD	0
use	use	VB	0
more	more	RBR	0
potent	potent	JJ	0
and	and	CC	0
specific	specific	JJ	0
inhibitors	inhibitors	NN	0
.	.	.	0
Methods	Methods	NNP	0
Platelet	Platelet	NNP	0
myosinII	myosinII	NNP	0
ATPase	ATPase	NNP	0
assay	assay	VBD	0
The	The	DT	0
assay	assay	NN	0
was	was	VBD	0
performed	performed	VBN	0
using	using	VBG	0
an	an	DT	0
EnzCheck	EnzCheck	JJ	0
phosphate	phosphate	JJ	0
release	release	NN	0
assay	assay	NNS	0
(	(	-LRB-	0
Molecular	Molecular	NNP	0
Probes	Probes	NNP	0
)	)	-RRB-	0
.	.	.	0
Platelet	Platelet	NNP	0
myosinII	myosinII	NNP	0
S1	S1	NNP	0
was	was	VBD	0
diluted	diluted	VBN	0
to	to	TO	0
0.050	0.050	CD	0
mg	mg	CD	0
/	/	CD	0
ml	ml	NN	0
in	in	IN	0
reaction	reaction	NN	0
buffer	buffer	NN	0
(	(	-LRB-	0
0.2	0.2	CD	0
M	M	NNP	0
KCl	KCl	NNP	0
,	,	,	0
10	10	CD	0
mM	mM	JJ	0
Tris	Tris	NNP	0
pH	pH	NNP	0
7.0	7.0	NNP	0
,	,	,	0
10	10	CD	0
mM	mM	JJ	0
CaCl	CaCl	JJ	0
2	2	CD	0
,	,	,	0
2	2	CD	0
mM	mM	JJ	0
MgCl	MgCl	JJ	0
2	2	CD	0
,	,	,	0
1	1	CD	0
mM	mM	JJ	0
DTT	DTT	NNP	0
,	,	,	0
0.2	0.2	CD	0
mM	mM	JJ	0
2-amino-6-mercapto-7-methyl	2-amino-6-mercapto-7-methyl	FW	0
purine	purine	FW	0
riboside	riboside	FW	0
(	(	-LRB-	0
MESG	MESG	NNP	0
)	)	-RRB-	0
in	in	IN	0
the	the	DT	0
presence	presence	NN	0
of	of	IN	0
1	1	CD	0
U	U	NNP	0
purine	purine	NN	B-NP
nucleoside	nucleoside	NN	I-NP
phosphorylase	phosphorylase	NN	I-NP
(	(	-LRB-	0
PNP	PNP	NNP	B-NP
)	)	-RRB-	0
)	)	-RRB-	0
.	.	.	0
dimethylsulphoxide	dimethylsulphoxide	NN	B-NP
,	,	,	0
20	20	CD	0
mM	mM	JJ	B-NP
BDM	BDM	NNP	I-NP
,	,	,	0
or	or	CC	0
100	100	CD	0
uM	uM	JJ	B-NP
blebbistatin	blebbistatin	NN	I-NP
was	was	VBD	0
added	added	VBN	0
to	to	TO	0
the	the	DT	0
reactions	reactions	NNS	0
with	with	IN	0
a	a	DT	0
constant	constant	JJ	0
DMSO	DMSO	NNP	B-NP
concentration	concentration	NN	I-NP
of	of	IN	0
1	1	CD	0
%	%	NN	0
.	.	.	0
ATP	ATP	NNP	B-NP
(	(	-LRB-	0
100	100	CD	0
uM	uM	NN	B-NP
)	)	-RRB-	0
was	was	VBD	0
added	added	VBN	0
to	to	TO	0
initiate	initiate	VB	0
the	the	DT	0
reaction	reaction	NN	0
and	and	CC	0
absorbance	absorbance	NN	B-NP
at	at	IN	0
360	360	CD	0
nm	nm	NN	B-NP
was	was	VBD	0
read	read	VBN	0
every	every	DT	0
~6	~6	CD	0
seconds	seconds	NNS	0
for	for	IN	0
20	20	CD	0
minutes	minutes	NNS	0
.	.	.	0
butanedione	butanedione	NN	B-NP
monoxime	monoxime	NN	I-NP
showed	showed	VBD	0
no	no	DT	0
effect	effect	NN	0
on	on	IN	0
atp	atp	NN	B-NP
hydrolysi	hydrolysi	NN	I-NP
in	in	IN	0
the	the	DT	0
myosin	myosin	NN	B-NP
absence	absence	NN	I-NP
.	.	.	0
Tissue	Tissue	NNP	0
Culture	Culture	NNP	0
BS-C-1	BS-C-1	NNP	0
cells	cells	NNS	0
and	and	CC	0
Swiss3T3	Swiss3T3	CD	0
cells	cells	NNS	0
were	were	VBD	0
acquired	acquired	VBN	0
from	from	IN	0
the	the	DT	0
ATCC	ATCC	NNP	0
(	(	-LRB-	0
CCL-26	CCL-26	NNP	0
,	,	,	0
CCL-92	CCL-92	CD	0
)	)	-RRB-	0
.	.	.	0
Cells	Cells	NNS	0
were	were	VBD	0
maintained	maintained	VBN	0
in	in	IN	0
Dulbecco	Dulbecco	NNP	0
's	's	POS	0
Modified	Modified	NNP	0
Essential	Essential	NNP	0
Medium	Medium	NNP	0
with	with	IN	0
4.5	4.5	CD	0
g	g	CD	0
/	/	CD	0
L	L	NNP	0
glucose	glucose	NN	0
,	,	,	0
10	10	CD	0
%	%	NN	0
fetal	fetal	JJ	0
calf	calf	JJ	0
serum	serum	NN	0
,	,	,	0
and	and	CC	0
penicillin	penicillin	CD	0
/	/	CD	0
streptomycin	streptomycin	NNS	0
.	.	.	0
Cells	Cells	NNS	0
were	were	VBD	0
maintained	maintained	VBN	0
at	at	IN	0
37C	37C	CD	0
with	with	IN	0
5	5	CD	0
%	%	NN	0
CO	CO	NNP	0
2	2	CD	0
.	.	.	0
Permeabilized	Permeabilized	JJ	B-NP
cell	cell	NN	I-NP
assay	assay	VBZ	0
permeabilized	permeabilized	NN	B-NP
cell	cell	NN	I-NP
assay	assay	NN	I-NP
were	were	VBD	0
performed	performed	VBN	0
in	in	IN	0
flow	flow	NN	B-NP
chamber	chamber	NN	I-NP
as	as	IN	0
previously	previously	RB	0
described	described	VBN	0
[	[	-LRB-	0
22	22	CD	0
]	]	-RRB-	0
.	.	.	0
Swiss3T3	Swiss3T3	NNP	0
cells	cells	NNS	0
were	were	VBD	0
flowed	flowed	VBN	0
into	into	IN	0
the	the	DT	0
chamber	chamber	NN	0
,	,	,	0
the	the	DT	0
chamber	chamber	NN	0
inverted	inverted	NN	0
,	,	,	0
and	and	CC	0
cells	cells	NNS	0
allowed	allowed	VBN	0
to	to	TO	0
spread	spread	VB	0
for	for	IN	0
30-45	30-45	CD	0
minutes	minutes	NNS	0
in	in	IN	0
a	a	DT	0
humidified	humidified	JJ	0
environment	environment	NN	0
at	at	IN	0
37C	37C	NNP	0
,	,	,	0
5	5	CD	0
%	%	NN	0
CO	CO	NNP	0
2	2	CD	0
.	.	.	0
The	The	DT	0
assay	assay	NN	B-NP
was	was	VBD	0
performed	performed	VBN	0
by	by	IN	0
adding	adding	VBG	0
50	50	CD	0
ul	ul	NN	B-NP
of	of	IN	0
the	the	DT	0
warmed	warmed	JJ	0
sample	sample	NN	B-NP
solution	solution	NN	I-NP
to	to	TO	0
the	the	DT	0
chamber	chamber	NN	0
while	while	IN	0
wicking	wicking	NN	B-NP
with	with	IN	0
Whatman	Whatman	NNP	B-NP
paper	paper	NN	I-NP
.	.	.	0
Cells	Cells	NNS	0
were	were	VBD	0
rinsed	rinsed	VBN	0
with	with	IN	0
phosphate	phosphate	NN	B-NP
buffered	buffered	NN	I-NP
saline	saline	JJ	I-NP
,	,	,	0
treated	treated	VBN	0
with	with	IN	0
compounds	compounds	NN	0
or	or	CC	0
media	media	NNS	0
for	for	IN	0
1	1	CD	0
min	min	NN	B-NP
,	,	,	0
permeabilized	permeabilized	VBG	0
in	in	IN	0
the	the	DT	0
presence	presence	NN	0
or	or	CC	0
compound	compound	NN	B-NP
absence	absence	NN	I-NP
for	for	IN	0
3	3	CD	0
min	min	NN	B-NP
with	with	IN	0
permeabilization	permeabilization	JJ	B-NP
buffer	buffer	NN	I-NP
(	(	-LRB-	0
0.02	0.02	CD	0
saponin	saponin	NN	B-NP
g/ml	g/ml	NN	I-NP
,	,	,	0
20	20	CD	0
mm	mm	NN	B-NP
hepe	hepe	NN	I-NP
(	(	-LRB-	0
pH	pH	NNP	B-NP
7.5	7.5	CD	0
)	)	-RRB-	0
,	,	,	0
138	138	CD	0
mM	mM	JJ	B-NP
KCl	KCl	NN	I-NP
,	,	,	0
4	4	CD	0
mM	mM	JJ	0
MgCl	MgCl	JJ	B-NP
2	2	CD	0
,	,	,	0
3	3	CD	0
mM	mM	JJ	B-NP
ETGA	ETGA	NNP	I-NP
,	,	,	0
1	1	CD	0
mM	mM	JJ	B-NP
DTT	DTT	NN	I-NP
+	+	FW	0
protease	protease	NN	B-NP
inhibitor	inhibitor	NN	I-NP
,	,	,	0
0.4	0.4	CD	0
uM	uM	JJ	B-NP
rhodamine	rhodamine	JJ	I-NP
actin	actin	NN	I-NP
,	,	,	0
1	1	CD	0
mM	mM	JJ	B-NP
ATP	ATP	NNP	I-NP
)	)	-RRB-	0
,	,	,	0
and	and	CC	0
fixed	fixed	VBN	B-NP
in	in	IN	0
phosphate	phosphate	NN	B-NP
buffered	buffered	NN	I-NP
saline	saline	JJ	I-NP
+	+	CD	0
3.7	3.7	CD	0
%	%	NN	0
formaldehyde	formaldehyde	NN	B-NP
for	for	IN	0
10	10	CD	0
min	min	NN	B-NP
.	.	.	0
Listeria	Listeria	FW	0
infection	infection	FW	0
listeria	listeria	NN	B-NP
monocytogene	monocytogene	NN	I-NP
(	(	-LRB-	0
strain	strain	FW	0
10403S	10403S	FW	0
)	)	-RRB-	0
were	were	VBD	0
grown	grown	VBN	0
overnight	overnight	JJ	0
in	in	IN	0
3	3	CD	0
ml	ml	NN	B-NP
of	of	IN	0
Brain	Brain	NNP	0
Heart	Heart	NNP	0
Infusion	Infusion	NNP	0
media	media	NNS	0
at	at	IN	0
room	room	NN	B-NP
temp	temp	NN	I-NP
without	without	IN	0
shaking	shaking	VBG	0
.	.	.	0
bs-c-1	bs-c-1	NN	B-NP
cell	cell	NN	I-NP
on	on	IN	0
25	25	CD	0
mm	mm	CD	B-NP
poly-L-lysine	poly-L-lysine	NN	I-NP
(	(	-LRB-	0
PLL	PLL	NNP	0
)	)	-RRB-	0
coverslip	coverslip	NN	B-NP
were	were	VBD	0
rinsed	rinsed	VBN	0
with	with	IN	0
media	media	NNS	0
containing	containing	VBG	0
no	no	DT	0
antibiotics	antibiotics	NN	0
and	and	CC	0
placed	placed	VBN	0
in	in	IN	0
a	a	DT	0
6	6	CD	0
well	well	NN	B-NP
plate	plate	NN	I-NP
.	.	.	0
Listeria	Listeria	NNP	B-NP
were	were	VBD	0
prepared	prepared	VBN	0
by	by	IN	0
removing	removing	VBG	0
1	1	CD	0
ml	ml	NN	0
of	of	IN	0
the	the	DT	0
overnight	overnight	JJ	0
culture	culture	NN	0
,	,	,	0
pelleting	pelleting	VBG	0
by	by	IN	0
a	a	DT	0
1	1	CD	0
min	min	NNP	B-NP
Eppendorf	Eppendorf	NN	I-NP
centrifuge	centrifuge	NN	I-NP
spin	spin	NN	I-NP
,	,	,	0
washing	washing	VBG	0
the	the	DT	0
pellet	pellet	NN	0
twice	twice	RB	0
with	with	IN	0
antibiotic-free	antibiotic-free	JJ	B-NP
medium	medium	JJ	I-NP
,	,	,	0
and	and	CC	0
resuspending	resuspending	NN	B-NP
in	in	IN	0
1	1	CD	0
ml	ml	NN	0
of	of	IN	0
media.	media.	CD	0
10	10	CD	0
listeria	listeria	NN	B-NP
ul	ul	NN	I-NP
were	were	VBD	0
added	added	VBN	0
to	to	TO	0
each	each	DT	0
well	well	RB	0
and	and	CC	0
were	were	VBD	0
allowed	allowed	VBN	0
to	to	TO	0
infect	infect	VB	0
for	for	IN	0
1.5	1.5	CD	0
hr	hr	NN	B-NP
prior	prior	RB	0
to	to	TO	0
the	the	DT	0
addition	addition	NN	B-NP
of	of	IN	0
media	media	NNS	0
containing	containing	VBG	0
50	50	CD	0
ug	ug	NN	B-NP
/	/	NN	I-NP
ml	ml	NN	I-NP
Gentamicin	Gentamicin	NN	I-NP
.	.	.	0
Cells	Cells	NNS	0
were	were	VBD	0
imaged	imaged	VBN	0
between	between	IN	0
4	4	CD	0
hr	hr	NN	B-NP
and	and	CC	0
12	12	CD	0
hr	hr	NN	B-NP
later	later	RB	0
.	.	.	0
immunofluorescence	immunofluorescence	JJ	B-NP
cell	cell	NN	I-NP
compound	compound	JJ	I-NP
treatment	treatment	NN	I-NP
were	were	VBD	0
allowed	allowed	VBN	0
to	to	TO	0
spread	spread	VB	0
on	on	IN	0
18	18	CD	0
mm	mm	JJ	B-NP
round	round	NN	I-NP
pll	pll	NN	I-NP
coverslip	coverslip	NN	I-NP
in	in	IN	0
a	a	DT	0
12	12	CD	0
well	well	NN	B-NP
plate	plate	NN	I-NP
for	for	IN	0
30-45	30-45	CD	0
minutes	minutes	NNS	0
or	or	CC	0
2-4	2-4	CD	0
hours	hours	NNS	0
prior	prior	RB	0
to	to	TO	0
treatment	treatment	NN	0
.	.	.	0
butanedione	butanedione	NN	B-NP
monoxime	monoxime	NN	I-NP
(	(	-LRB-	0
Calbiochem	Calbiochem	NNP	B-NP
203984	203984	CD	0
)	)	-RRB-	0
stock	stock	NN	B-NP
solution	solution	NN	I-NP
was	was	VBD	0
made	made	VBN	0
in	in	IN	0
media	media	NNS	0
at	at	IN	0
0.5	0.5	CD	0
M	M	NNP	0
and	and	CC	0
Cytochalasin	Cytochalasin	NNP	B-NP
D	D	NNP	I-NP
(	(	-LRB-	0
Sigma	Sigma	NNP	B-NP
C8273	C8273	NNP	0
)	)	-RRB-	0
in	in	IN	0
dimethylsulphoxide	dimethylsulphoxide	NN	B-NP
at	at	IN	0
20	20	CD	0
mM	mM	NN	0
.	.	.	0
With	With	IN	0
the	the	DT	0
plate	plate	NN	0
on	on	IN	0
a	a	DT	0
37C	37C	JJ	0
heat	heat	NN	B-NP
block	block	NN	I-NP
,	,	,	0
appropriately	appropriately	RB	0
diluted	diluted	VBN	B-NP
concentration	concentration	NN	I-NP
of	of	IN	0
each	each	DT	0
compound	compound	NN	B-NP
(	(	-LRB-	0
15	15	CD	0
or	or	CC	0
20	20	CD	0
mM	mM	JJ	B-NP
BDM	BDM	NNP	I-NP
,	,	,	0
1	1	CD	0
uM	uM	JJ	B-NP
cytochalasin	cytochalasin	JJ	I-NP
D	D	NNP	0
)	)	-RRB-	0
were	were	VBD	0
made	made	VBN	0
in	in	IN	0
warmed	warmed	JJ	0
media	media	NNS	0
and	and	CC	0
added	added	VBD	0
to	to	TO	0
cells	cells	NNS	0
after	after	IN	0
removal	removal	NN	0
of	of	IN	0
existing	existing	VBG	0
media	media	NNS	0
.	.	.	0
After	After	IN	0
1	1	CD	0
minute	minute	NN	0
,	,	,	0
the	the	DT	0
cells	cells	NNS	0
were	were	VBD	0
fixed	fixed	VBN	B-NP
for	for	IN	0
immunoflourescence	immunoflourescence	VBG	0
as	as	RB	0
described	described	VBN	0
below	below	RB	0
.	.	.	0
immunofluorescence	immunofluorescence	NN	B-NP
cell	cell	NN	I-NP
were	were	VBD	0
fixed	fixed	VBN	B-NP
in	in	IN	0
a	a	DT	0
permeabilization	permeabilization	NN	B-NP
/	/	NN	I-NP
fixation	fixation	NN	I-NP
buffer	buffer	NN	I-NP
(	(	-LRB-	0
100	100	CD	0
mM	mM	JJ	B-NP
K-Pipes	K-Pipes	JJ	I-NP
pH	pH	JJ	I-NP
6.8	6.8	CD	0
,	,	,	0
10	10	CD	0
mM	mM	JJ	B-NP
EGTA	EGTA	NNP	I-NP
,	,	,	0
1	1	CD	0
mM	mM	JJ	B-NP
MgCL2	MgCL2	NN	I-NP
,	,	,	0
0.2	0.2	CD	0
%	%	NN	0
TritonX-100	TritonX-100	NN	B-NP
,	,	,	0
3.7	3.7	CD	0
%	%	NN	0
formaldehyde	formaldehyde	NN	B-NP
)	)	-RRB-	0
for	for	IN	0
10	10	CD	0
minutes	minutes	NNS	0
.	.	.	0
For	For	IN	0
Arp3	Arp3	CD	B-NP
immunofluorescence	immunofluorescence	NN	I-NP
,	,	,	0
cells	cells	NNS	0
were	were	VBD	0
post-fixed	post-fixed	JJ	0
in	in	IN	0
methanol	methanol	NN	0
(	(	-LRB-	0
-20C	-20C	NNP	0
)	)	-RRB-	0
for	for	IN	0
2	2	CD	0
minutes	minutes	NNS	0
.	.	.	0
coverslip	coverslip	NN	B-NP
were	were	VBD	0
rinsed	rinsed	VBN	0
with	with	IN	0
tb	tb	NN	B-NP
containing	containing	VBG	0
0.1	0.1	CD	0
%	%	NN	0
Triton	Triton	NNP	B-NP
X-100	X-100	NNP	I-NP
(	(	-LRB-	0
TBS-Tx	TBS-Tx	NNP	B-NP
)	)	-RRB-	0
and	and	CC	0
blocked	blocked	VBN	0
in	in	IN	0
TBS-Tx	TBS-Tx	JJ	B-NP
with	with	IN	0
2	2	CD	0
%	%	NN	0
bovine	bovine	JJ	B-NP
serum	serum	NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
albumin	albumin	NN	I-NP
(	(	-LRB-	0
AbDil	AbDil	NNP	B-NP
)	)	-RRB-	0
for	for	IN	0
45	45	CD	0
minutes	minutes	NNS	0
.	.	.	0
antibody	antibody	NN	B-NP
were	were	VBD	0
diluted	diluted	VBN	0
in	in	IN	0
AbDil	AbDil	JJ	0
and	and	CC	0
incubated	incubated	NN	0
for	for	IN	0
45	45	CD	0
minutes	minutes	NNS	0
.	.	.	0
coverslip	coverslip	NN	B-NP
were	were	VBD	0
rinsed	rinsed	VBN	0
in	in	IN	0
TBS-Tx	TBS-Tx	JJ	B-NP
and	and	CC	0
incubated	incubated	NN	0
with	with	IN	0
fluorescently	fluorescently	NN	0
labeled	labeled	VBD	0
secondary	secondary	JJ	B-NP
antibody	antibody	NN	I-NP
in	in	IN	0
TBS-Tx	TBS-Tx	JJ	B-NP
for	for	IN	0
45	45	CD	0
minutes	minutes	NNS	0
.	.	.	0
coverslip	coverslip	NN	B-NP
were	were	VBD	0
rinsed	rinsed	JJ	0
and	and	CC	0
mounted	mounted	VBN	0
in	in	IN	0
90	90	CD	0
%	%	NN	0
glycerol	glycerol	NN	B-NP
with	with	IN	0
0.5	0.5	CD	0
%	%	NN	0
p-phenylenediamine	p-phenylenediamine	NN	B-NP
in	in	IN	0
20	20	CD	0
mM	mM	JJ	B-NP
Tris-pH	Tris-pH	JJ	I-NP
8.8	8.8	CD	0
.	.	.	0
antibody	antibody	NN	B-NP
used	used	VBN	0
:	:	:	0
rabbit	rabbit	CD	B-NP
arp3	arp3	NN	I-NP
antibody	antibody	NN	I-NP
(	(	-LRB-	0
gift	gift	NN	0
from	from	IN	0
C.	C.	NNP	0
Egile	Egile	NNP	B-NP
using	using	VBG	0
the	the	DT	0
same	same	JJ	0
peptide	peptide	NN	B-NP
as	as	IN	0
described	described	VBN	0
[	[	-LRB-	0
33	33	CD	0
]	]	CD	0
)	)	-RRB-	0
used	used	VBN	0
at	at	IN	0
1	1	CD	0
:	:	:	0
500	500	CD	0
dilution	dilution	NN	0
,	,	,	0
mouse	mouse	NN	B-NP
actin	actin	NN	I-NP
antibody	antibody	NN	I-NP
(	(	-LRB-	0
Santa	Santa	NNP	B-NP
Cruz	Cruz	NNP	I-NP
SC-8432	SC-8432	NNP	I-NP
)	)	-RRB-	0
used	used	VBN	0
at	at	IN	0
1	1	CD	0
:	:	:	0
10,000	10,000	CD	0
dilution	dilution	NN	0
,	,	,	0
rabbit	rabbit	NN	B-NP
vasp	vasp	NN	I-NP
antibody	antibody	NN	I-NP
(	(	-LRB-	0
gift	gift	NN	0
from	from	IN	0
F.	F.	NNP	0
Southwick	Southwick	NNP	0
)	)	-RRB-	0
used	used	VBN	0
at	at	IN	0
1	1	CD	0
:	:	:	0
100	100	CD	0
,	,	,	0
rabbit	rabbit	NN	B-NP
wave1	wave1	NN	I-NP
antibody	antibody	NN	I-NP
(	(	-LRB-	0
gift	gift	NN	0
from	from	IN	0
S.	S.	NNP	0
Eden	Eden	NNP	0
as	as	RB	0
described	described	VBN	0
[	[	-LRB-	0
26	26	CD	0
]	]	CD	0
)	)	-RRB-	0
used	used	VBN	0
at	at	IN	0
1	1	CD	0
:	:	:	0
100	100	CD	0
and	and	CC	0
Alexa-dye	Alexa-dye	NNP	B-NP
labeled	labeled	VBD	0
secondary	secondary	JJ	B-NP
antibody	antibody	NN	I-NP
,	,	,	0
goat	goat	JJ	B-NP
anti-rabbit	anti-rabbit	JJ	I-NP
and	and	CC	0
goat	goat	JJ	B-NP
anti-mouse	anti-mouse	NN	I-NP
(	(	-LRB-	0
molecular	molecular	JJ	B-NP
probe	probe	NN	I-NP
)	)	-RRB-	0
.	.	.	0
GFP-Arp3	GFP-Arp3	NNP	0
cell	cell	NN	0
line	line	NN	0
A	A	DT	0
stable	stable	JJ	0
BS-C-1	BS-C-1	CD	0
cell	cell	NN	0
line	line	NN	0
was	was	VBD	0
made	made	VBN	0
by	by	IN	0
transfection	transfection	NN	0
of	of	IN	0
GFP-Arp3	GFP-Arp3	NNP	0
(	(	-LRB-	0
gift	gift	NN	0
from	from	IN	0
D.	D.	NNP	0
Schafer	Schafer	NNP	0
as	as	RB	0
described	described	VBN	0
[	[	-LRB-	0
34	34	CD	0
]	]	CD	0
)	)	-RRB-	0
using	using	VBG	0
Fugene6	Fugene6	NNP	0
(	(	-LRB-	0
Roche	Roche	NNP	0
)	)	-RRB-	0
and	and	CC	0
selection	selection	NN	0
with	with	IN	0
500	500	CD	0
ug	ug	FW	0
/	/	FW	0
ml	ml	FW	0
Geneticin	Geneticin	FW	0
.	.	.	0
GFP	GFP	NNP	0
expressing	expressing	VBG	0
colonies	colonies	NNS	0
were	were	VBD	0
picked	picked	VBN	0
and	and	CC	0
expanded	expanded	VBN	0
.	.	.	0
Live	Live	JJ	0
imaging	imaging	NN	0
of	of	IN	0
gfp-arp3	gfp-arp3	NN	B-NP
gfp-arp3	gfp-arp3	NN	I-NP
cell	cell	NN	I-NP
were	were	VBD	0
split	split	VBN	0
onto	onto	IN	0
25	25	CD	0
coated	coated	VBN	B-NP
coverslip	coverslip	NN	I-NP
mm	mm	NN	I-NP
pll	pll	NN	I-NP
4-6	4-6	FW	0
hrs	hrs	FW	0
before	before	IN	0
imaging	imaging	NN	0
.	.	.	0
Cells	Cells	NNS	0
were	were	VBD	0
transferred	transferred	VBN	0
to	to	TO	0
liebovitz	liebovitz	NN	B-NP
l-15	l-15	NN	I-NP
medium	medium	JJ	I-NP
with	with	IN	0
10	10	CD	0
%	%	NN	0
fetal	fetal	JJ	B-NP
calf	calf	JJ	I-NP
serum	serum	NN	I-NP
in	in	IN	0
a	a	DT	0
heated	heated	JJ	0
(	(	-LRB-	0
37C	37C	NNP	0
)	)	-RRB-	0
open-air	open-air	JJ	0
chamber	chamber	NN	0
15	15	CD	0
minutes	minutes	NNS	0
prior	prior	RB	0
to	to	TO	0
imaging	imaging	VB	0
.	.	.	0
Images	Images	NNS	0
were	were	VBD	0
captured	captured	VBN	0
on	on	IN	0
a	a	DT	0
Nikon	Nikon	NNP	B-NP
TE300	TE300	NNP	I-NP
inverted	inverted	JJ	0
microscope	microscope	NN	B-NP
with	with	IN	0
appropriate	appropriate	JJ	0
neutral	neutral	JJ	B-NP
density	density	NN	I-NP
filtering	filtering	VBP	0
using	using	VBG	0
an	an	DT	0
Apo	Apo	NNP	0
100	100	CD	0
		CD	0
/	/	CD	0
1.4	1.4	CD	0
NA	NA	JJ	B-NP
oil	oil	NN	I-NP
emersion	emersion	NN	I-NP
phase	phase	NN	I-NP
objective	objective	NN	I-NP
and	and	CC	0
captured	captured	VBN	0
on	on	IN	0
a	a	DT	0
CCD	CCD	NNP	0
camera	camera	NN	0
(	(	-LRB-	0
Hammamatsu-OrcaER	Hammamatsu-OrcaER	NNP	B-NP
)	)	-RRB-	0
using	using	VBG	0
Metamorph	Metamorph	JJ	B-NP
software	software	NN	I-NP
.	.	.	0
Images	Images	NNS	0
were	were	VBD	0
taken	taken	VBN	0
every	every	DT	0
15	15	CD	0
s	s	NN	0
with	with	IN	0
an	an	DT	0
exposure	exposure	NN	0
of	of	IN	0
200-1000	200-1000	CD	0
m	m	NN	B-NP
.	.	.	0
Authors	Authors	NNP	0
'	'	POS	0
contribution	contribution	NN	B-NP
JY	JY	VBP	0
prepared	prepared	VBN	0
the	the	DT	0
manuscript	manuscript	NN	0
and	and	CC	0
performed	performed	VBD	0
the	the	DT	0
time-lapse	time-lapse	JJ	B-NP
microscopy	microscopy	NN	I-NP
,	,	,	0
Listeria	Listeria	NNP	B-NP
,	,	,	0
and	and	CC	0
myosin	myosin	JJ	B-NP
atpase	atpase	NN	I-NP
experiment	experiment	NN	I-NP
.	.	.	0
Remaining	Remaining	VBG	B-NP
experimentswera	experimentswera	NN	I-NP
done	done	VBN	0
in	in	IN	0
collaboration	collaboration	NN	B-NP
with	with	IN	0
TL	TL	NNP	B-NP
.	.	.	0
RL	RL	NNP	B-NP
and	and	CC	0
TM	TM	NNP	B-NP
supervised	supervised	VBD	0
this	this	DT	0
work	work	NN	0
and	and	CC	0
provided	provided	VBN	0
funding	funding	NN	0
and	and	CC	0
support	support	NN	0
.	.	.	0
All	All	DT	0
authors	authors	NNS	0
read	read	VBP	0
and	and	CC	0
approved	approved	VBD	0
the	the	DT	0
final	final	JJ	B-NP
manuscript	manuscript	NN	I-NP
.	.	.	0
